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Résumé 
 
L’expression de la protéine ICP22 de l’herpesvirus GaHV-2 a été décrite comme étant induite 
par un mécanisme dépendant de la liaison d’un microARN. Les résultats préliminaires 
décrivent une augmentation de l’expression aussi bien au niveau transcriptionnel que 
traductionnel. Les mécanismes sous-tendant cette augmentation n’ont pas été élucidés. 
L’objectif premier de ce mémoire de master était d’établir des constructions rapportrices de 
l’induction naturelle par le microARN dans le but de confirmer et de décortiquer les tenants et 
aboutissants de cette induction naturelle. 
Les premiers résultats obtenus ont mis en lumière la présence d’une structure secondaire de 
l’ARN messager au niveau du site cible du microARN étudié. Cette structure en épingle à 
cheveux s’est révélée importante aussi bien au niveau transcriptionnel que traductionnel, au 
même titre que le microARN dont des effets à la fois directs et indirects ont été démontrés. 
Bien que non-étudiés à l’heure actuelle, plusieurs modèles mécanistiques ont été proposés sur 
base des résultats et de la littérature. Ces mécanismes, non-exclusifs, invoquent la présence de 
la structure de l’ARN messager et du microARN. 
Le virus devenant de plus en plus virulent au cours du temps, les vaccins approchant de 
l’obsolescence, les mécanismes proposés ouvrent la voie à de possibles nouveaux types de 
vaccins viraux atténués par l’expression d’éventuelles protéines délétères pour le cycle viral. 
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Summary 
 
Gene expression concerning the ICP22 protein, encoded by the Gallid herpesvirus type 2, was 
described as being induced by a mechanism depending on the binding of a microRNA to the 
messenger RNA. Preliminary results described an expression increase at both the 
transcriptional and translational levels. Mechanisms that underlie this increase were not 
elucidated yet. 
The first aim of this master thesis was the establishment of constructs reporting the natural 
miRNA-mediated enhancement in order to confirm and to decipher the ins and outs of this 
natural enhancement. 
The first obtained results shed light at a secondary structure belonging to the messenger RNA, 
localized at the microRNA binding site. This hairpin structure was revealed to have a 
prominent role at both the transcriptional and translational levels. The microRNA was also 
shown to play a substantial role which was both direct and indirect. 
Although they were not studied yet, several mechanistic models were suggested based on the 
results and on literature. These non-exclusive mechanisms involve both the microRNA and 
the described hairpin. 
As the virus becoming increasingly virulent over time, concomitant with the approaching 
obsolescence of the current vaccines, it is important to find new ways to protect the impacted 
animals. The suggested mechanisms open a gate to new alternative ways to engineer new 
vaccine strains, attenuated by the expression of proteins deleterious for the viral life cycle. 
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 Figure 1 : Examples RNA structures. A) First ribozymes discovered in Tetrahymena thermophila in 1982. The 
paired helical elements are designated by “P" (from P1 to P9) and joining regions by "J". Some helical elements 
are not detailed but represented by dashed lines (Golden et al, 1998). B) Secondary structure of a hammerhead 
ribozyme and its boundaries with itself. The thick black lines represents the continuity of the backbone (Swadling 
et al, 2019). C) Structure of the 16S rRNA of an E.coli bacteria (Woese et al,1990). D) Secondary structure of the 
human selenocysteine-tRNA. The red color represents the acceptor arm, where the amino acid is bound. The 
orange color represents the T arm that binds to EF-Tu. The yellow color represents the extra arm, that allows 
selenocysteine to bind to the tRNA. The green color represents the anticodon arm. The blue color represents the 
D arm, that binds to EF-P (Itoh et al, 2013). 
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1) Introduction 
1.1) RNA as the basis of life 
The gene expression is still described as a linear pathway, known as central dogma. This dogma 
assumes that DNA is transcribed into a messenger RNA (mRNA) which is translated into a 
protein. This stereotypic view of the gene expression has successively been disrupted by 
discoveries such as ribozymes, retroviruses and post-transcriptional or post-translational 
modifications (Hartenian and Glaunsinger, 2019). 
A major hypothesis about the origin of life suggests that the very first organic forms of life were 
RNA-based and protein-free. At the early time of life, RNA, structured into ribozymes, was 
able to self-replicate and to produce new RNA forms, such as aptamers. One major observation 
that supports this hypothesis is the ubiquity of the RNA in a lot of different shapes for basal 
functions of a cell. From small nucleolar RNAs to transfer RNAs and spliceosomes, RNA is 
always needed in order to produce proteins. However, proteins are not always necessary to 
synthetize RNA. And as a proof of concept, RNA viruses show that a DNA template is not 
needed to generate a simple life form (Mustafin and Khusnutdinova, 2019). 
1.1.1) RNA secondary structures 
RNA structures have many roles in a lot of pathways. Despite this fact, it is still difficult to 
understand and to know precisely the whole diversity of shapes that RNA can have. However, 
what is known today, thanks to bioinformatics, molecular biology and chemistry, allows 
making boundaries in the structure/function relationship that makes RNA the central 
component of the life (Swadling et al., 2018; Weeks, 2010). The following paragraphs tend to 
show, in a non-exhaustive manner, the value of establishing secondary structures in RNA 
molecules. It is important to note that tertiary structures are common among RNAs but skipped 
in this paragraph.  
3.9 billion years ago, in a world that was protein-free, emerged some molecules able to self-
replicate. Ribozymes are probable candidates for being these molecules (Figure 1.A.). At this 
time, they synthetized themselves using minerals as chaperones to resist under extreme 
conditions, such as the extreme temperature variations. One of the first ribozyme was thus 
probably a RNA-dependent RNA polymerase (RNAP), beginning the RNA-only pathway that 
lead to life (Mustafin and Khusnutdinova, 2019; Swadling et al., 2018). 
Next to this, when RNA became abundant and diverse thanks to mutations caused by UV-light 
and poor fidelity of the first RNAP, hammerhead ribozymes (Figure 1.B.) may have appeared, 
increasing thereby the diversity in the RNA world. This ribozyme has a nucleolytic function 
either on itself or on other RNAs due to its conformation. It encompasses two loops which, 
when modified, gave its role to the molecule. More precisely, the mutations in the loops change 
the affinity of the hammerhead for itself or for other RNAs (De la Pena, 2003; Swadling et al., 
2018). 
When amino acids have been present in the primitive surrounding environment (Miller, 1953), 
ribosomal RNA (rRNA) have emerged as highly structured RNA constitutive of the primitive 
ribosome, able to support the first protein synthesis. Even in the human cells, the ribosomal 
catalytic core is still only composed of RNAs, highly conserved in all the species (Swadling et 
al., 2018). As an example, the 16S RNA of Escherichia coli is made of a large series of stem-
loops (Figure 1.C) (Woese et al., 1990). 
To produce proteins in the proper way with the proper amino acids, adapter RNAs were 
generated to make a link between the RNA template and the amino acids. These adapters are 
the transfer RNAs (tRNA) and have one of the most known structure-function relationships  
 Figure 2 : Summary of the initiation of the eukaryotic translation. A) The mRNA displays both a 5’-m7-GTP 
cap and a 3’-poly A tail. The m7GTP-cap recruits eIF4E (4E) and the poly A tail recruits PABP. eIF4G (4G) is 
recruited on the m7GTP-cap by 4E. B) 4G recruits both eIF3 (3) bound to the SSU of the ribosome (with a tRNA 
on the A site) and PABP which makes the mRNA take a circular shape. C) The A site of the ribosomal SSU is left 
free by a methionylated tRNA that moves to the P site. This changes the ribosomal conformation, which allow it 
to go through the scanning of the mRNA. D and E) Thanks to the codon-anticodon interaction, the ribosome stalls 
at the start-codon. This stalling allows recruiting the LSU of the ribosome, which permits the synthesis of the 
protein (created from Weisser and Ban, 2019). 
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among RNAs. They are made of 3 (or 4 in some cases) hairpins and one arm of double stranded 
RNA (dsRNA). The double strand is the acceptor arm, and it makes the boundary with the 
amino acid at the 3’ end. One of the hairpin is the anticodon and allows the recognition of the 
matching codon, according to which amino acid is bound to the first arm. The T and D loop are 
respectively bound with elongation factors (EF) Tu and P. Sometimes, an extra loop can exist 
and is used to help the ligation of the amino acid on the first arm (Figure 1.D.) (Itoh et al., 2013; 
Katoh et al., 2017; Ohtsuki and Watanabe, 2007). 
Finally, over time, the RNA regulation became more and more complex and the functions 
diversified. RNA structures acquired the competency to regulate genic expression either in cis 
or in trans, but also to be used as a platform to recruit proteins (Swadling et al., 2018). Viruses 
do not make an exception, they also use several RNA structures to complete their life cycle. In 
this paragraph, it was chosen to only focus on hairpins. For example, in Hepatitis C Virus 
(HCV), hairpins harbor major roles. First, the 5’end structures are used as riboswitches to 
monitor the replication rate. In this case, the structure can take two alternative conformations. 
This property is used by the virus to turn on (or not) its replication (Boerneke and Hermann, 
2015). The second role of the structure is to be used as an internal ribosome entry site (IRES) 
to translate the viral proteins. The IRES are a common feature of the mRNA to launch 
translation in a cap-independent manner (Svoboda and Cara, 2006). Another role is involved 
during replication, where the RNA-dependent RNAP of HCV uses one strand of the hairpin as 
a primer to synthetize the other strand, in a mechanism named “copy-back replication” (Behrens 
et al., 1996). 
1.1.2) Translational regulation 
Nowadays, one of the major role of the RNAs in the eukaryotic domain of life is the regulation 
of gene expression. Notably, the translation of a mRNA results usually in the expression of a 
protein. These proteins take a major place in the life cycle of a cell. Thus, the protein 
homeostasis is a critical scaffold that maintain the cell homeostasis (Hartenian and Glaunsinger, 
2019).  
During gene expression, several mechanisms ensure protein homeostasis. These mechanisms 
prevent the production of defective proteins that might have a deleterious dominant negative 
effect on the cell or even the organism. The detected mutated proteins are usually submitted to 
degradation, as well as the mutated transcript (Hildebrandt et al., 2019; Simms et al., 2017). 
Three major ways to decay aberrant mRNA are commonly described : Nonsense-mediated 
mRNA decay (NMD), Non-stop decay (NSD) and No-go decay (NGD) (Simms et al., 2017). 
1.1.2.1) Canonical translation 
Translation initiation 
The translation begins with the initiation step (Figure 2). The small ribosomal subunit (SSU), 
with a methionylated transfer RNA (tRNA), is recruited on the mRNA, at its 5’end, thanks to 
the 5’ cap, recognized by initiation factors. The methionylated tRNA takes place first at the A 
site of the ribosomal subunit. During translation, the tRNA can take three places in the 
ribosome: A, P and E. The precise roles of these places can be summarized as follow: the tRNA 
arrives at the A site (A=aminoacyl), it elongates the nascent peptide at the P site (P=peptidyl) 
and it leaves the ribosome through the E site (E=exit). The binding of the mRNA to the SSU 
makes it take a circularized conformation, mediated by the interaction that gathers m7GTP – 
eIF4E – eIF4G – PABP (eIF : eukaryotic initiation factor ; PABP : Poly-A binding protein). 
Then, the tRNA leaves the A site of the ribosome free and move to the P site, this configuration 
makes the SSU able to scan the mRNA until it reaches the start codon (AUG). There, it changes 
its  
 Figure 3: Canonical termination of 
the translation. A and B) At the stop 
codon, the ribosome pauses (mediated 
by its interaction with PABP) and 
recruits eRF1 (R1) bound to eRF3-GTP 
(R3-GTP). C) The hydrolysis of the 
GTP on eRF3 activates eRF1 which 
changes its conformation and D) 
releases the peptide. The proximity of 
PABP with the translation complex 
inhibits the binding of decay factors 
(DF), such as Upf-1. E) Next to the 
dissociation of eRF3, eRF1 recruits 
ABCE1 which allows recycling the 
translation machinery. F) eRF1 and 
ABCE1 are released from the mRNA 
when termination is completed. 
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conformation and the large ribosomal subunit (LSU) is able to bind to the SSU to form a proper 
ribosome, prone to translate the mRNA (Weisser and Ban, 2019).  
Translation Termination 
When reaching the stop codon (UAA, UAG or UGA) (Figure 3), the ribosome pauses and 
recruits eRF1 (eukaryotic release factor 1) to its A site. eRF 1 is bound to the eRF3 GTPase. 
The hydrolysis of a phosphate by eRF3 changes the conformation of eRF1 which activates the 
peptidyl-transferase activity of the ribosome and releases the peptide. The dissociation of eRF3 
allows eRF1 recruiting ABCE1 which permits to detach the LSU and recycle the termination 
complex (Kervestin and Jacobson, 2012). 
The GTPase activity of eRF3 is mediated by PABP, giving a role to PABP during the whole 
translation mechanism. Actually, the absence of PABP alters both initiation and termination, 
increasing the readthrough after nonsense codons (Kervestin and Jacobson, 2012). 
Sometimes, in bicistronic transcripts, the SSU might remain bound to the mRNA and launch a 
new initiation event allowing the translation of the downstream ORF (dORF). This dORF is 
often less translated than the upstream one (uORF). The reinitiation is dependent on features 
such as the mRNA structures, the context surrounding both the uORF stop codon and the dORF 
start codon and the intergenic region (IgR) length (Wethmar, 2014). 
1.1.2.2) Nonsense-mediated mRNA decay 
When a premature termination codon (PTC) is scanned by the ribosome in an inappropriate 
context, the NMD pathway degrades the transcript. Inappropriate context can be a long 3’ 
untranslated region (UTR) that does not permit the interaction between PABP and the 
ribosome-associated proteins, as well as the remaining presence of exon junction complexes 
that recruit Up factors or mRNA that are subject to frameshifting. In all these case, eRF3 does 
not leave the ribosome and Upf1 (Up factor 1) is recruited. The latter is phosphorylated right 
after being bound to Upf2 and 3. The active form of Upf1 has an ATPase and a helicase 
activities. It leads to the peptide degradation and to the recycling of the components of the 
ribosome (Celik et al., 2015; Porrua and Libri, 2013, 2015). 
1.1.2.3) Non-stop decay 
Due to splicing or mutations, some mRNA are lacking a proper stop codon in the proper reading 
frame. This results in two types of transcripts: the nonstop transcripts and the stop codon-less 
transcripts. The nonstop transcripts encompass a poly-A tail since they come from a premature 
polyadenylation of the transcript. The second type do not encompass their poly-A tail, probably 
because of an endonucleolytic cleavage of the mRNA. Both of them are regulated by the NSD. 
This mechanism is poorly understood but when the mRNA carries its poly-A tail, it is assumed 
that the translation of the successive adenines, producing successive lysines, creates a strong 
positive charge around the exit tunnel of the ribosome, negatively charged. Thus, there is an 
interaction between the peptide and the ribosome, which stalls the ribosome on the poly-A. This 
stalling makes the ribosome empty on its A site for a long time. Thus, it recruits a complex 
made of Pelota and HBS1 which are parologs of eRF1 and eRF3 but they lack the sequence that 
recognize the stop codon and the sequence that allow the peptide release. It launches the release 
of the LSU but with the peptide still bound to it. This is recognized by a ribosome-associated 
quality control (RaQC) and the peptide is degraded. Concerning the mRNA, the recognition by 
the NSD complex triggers its degradation in a Ski7-mediated way (Simms et al., 2017; 
Szádeczky-Kardoss et al., 2018). 
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1.1.2.4) No-Go Decay 
NGD occurs when the ribosome is stopped during elongation. This stop can be due to several 
features of the mRNA : premature termination codons, poly-basic amino acids stretches, rare 
codons, chemically modified nucleotides, or some secondary structures in the mRNA, such as 
hairpins. The stalling leads to ribosome collisions at the stalling site. These collisions trigger 
the phosphorylation of some ribosomal proteins, which recruits an RNA decay complex 
(Szádeczky-Kardoss et al., 2018). This complex is made of HBS1 and Dom34 which trigger an 
endonucleolytic cleavage of the mRNA in the presence of ABCE1. This cleavage results in two 
mRNA pieces that are degraded by Xrn-1 (Ikeuchi and Toshifumi, 2016). 
  
  
Figure 4 : Animal miRNA biogenesis and function. A) In the nucleus, miRNA are transcribed from DNA either 
from genic or intergenic regions by the RNAPII. B) A pri-miRNA transcript that contains a hairpin in its secondary 
structure is processed by Drosha to cleave the linear regions of the transcript. C) The hairpin is recruited by the 
exportin-5 which is used as a cargo to go out the nucleus. D) Outside the nucleus, the hairpin is processed by Dicer 
to cleave the loop of the hairpin. E) The double-stranded RNA is recruited by RISC, which select a strand following 
the stability of the 5’ ends of the strands. The miRISC complex exert its function either on the DNA or on the 
RNA. F) Some miRNA, called saRNA, bind directly on the DNA at the promoters of some genes. They can alter 
the transcription positively or negatively by interacting with transcription factors, methylation or histones. G) Most 
of the known animal miRNA bind to mRNA. A perfect match (rare) cleaves the transcript, meanwhile an imperfect 
match alters the stability or the translation either positively or negatively. 
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1.2) MicroRNA’s : Functions and regulations 
MicroRNAs (miRNA) (Figure 4) are small non-coding RNAs transcribed by metazoans and 
plants discovered in 1998 (Fire et al., 1998). They take part in RNA interference through a 
sequence-specific silencing of target genes. They can either destabilize mRNAs or alter their 
transcription and their translation either positively or negatively. They are mostly transcribed 
by RNAPII from either intronic or exonic region in the genome or even from intergenic regions. 
The transcripts (primiR) encompass a highly stable structure, a hairpin, that is processed by 
Drosha (a type III RNase) to build a pre-miR exported out of the nucleus. In the cytoplasm, 
Dicer (another type III RNase) cleaves the hairpin to make a double-strand RNA of an average 
size of 22 nucleotides. One of the strands is incorporated into the RNA-induced silencing 
complex (RISC) which contains an Argonaute protein (Ago) to become the miRISC complex. 
Usually, the selected strand is the one that has the less stably paired nucleotides at its 5’ end. 
The non-selected strand is usually released and then degraded (Fischer, 2015; Krol et al., 2010; 
Michlewski and Cáceres, 2019). 
Drosha and Dicer 
The reaction catalyzed by Drosha, in the nucleus, involves several proteins, including the 
double stranded RNA-binding protein DGCR8 (DiGeorge syndrome critical region 8). The 
reaction produces a ~70 nucleotides hairpin which is the pre-miRNA. Exportin-5 leads the pre-
miRNA outside the nucleus to be processed by Dicer (Michlewski and Cáceres, 2019). 
Dicer, with its cofactor proteins, processes the pre-miRNA to build the miRNA duplex 
incorporated into RISC with Ago. The cleavage processed by Dicer is often imprecise and can 
create several duplex variants that lead to different miRNAs at the end of the processing 
(Michlewski and Cáceres, 2019). 
Seed Sequence 
The most functional part of a miRNA is the seed sequence made of the nucleotides 2 to 8 at the 
5’end of the miRNA mature sequence. The miRISC activity depends on the length of miRNA-
mRNA hybridization. When the match between the mRNA and the miRNA is imperfect, there 
is a translational repression of the target or a recruitment of the mRNA turnover machinery. In 
the case of perfect match between the full miRNA sequence with the target mRNA, the cleavage 
of the mRNA is observed (Ameres and Zamore, 2013; Fischer, 2015; Krol et al., 2010; 
Michlewski and Cáceres, 2019). 
However, the seed is not the only interactional part of the miRNA. Three types of interactions 
have been described : 5’ canonical, 5’ dominant and 3’ compensatory. In the first case, the seed 
sequence is paired with the mRNA and completed with several nucleotides paired in 3’. In the 
second case, only the seed is paired with the mRNA. In the third case, the seed sequence is 
paired badly but a 3’ pairing allows the miRNA to keep its function (Brennecke et al., 2005). 
A fourth case is also admitted, the so-called “G-bulge interaction” where the seed sequence 
matches almost perfectly with a sequence except on a G within the mRNA (Ameres and 
Zamore, 2013). 
Mechanism of action 
The most known mechanism have a negative impact on the gene expression. When a miRNA 
sequence does not fully match to its target, there is no cleavage of the target by Ago2. However, 
there is other ways of silencing a transcript. In animals, this is the case for most of the targeted 
transcripts. The miRISC complex either represses translation, or promotes deadenylation of the 
mRNA and leads it to decay (Ameres and Zamore, 2013). 
 Figure 5 :  miRNA-mediated stabilization of a transcript by inhibition of the binding of a deletorious protein. 
In the absence of miR466l, the mRNA encoding for IL-10 is targeted by TTP, which binds to ARE and destabilizes 
the transcript. In the presence of miR466l, the binding is inhibited. The miRNA-induced destabilization is weaker 
than the TTP-induced one (Ma et al, 2010). 
 
 
Figure 6 : miRNA-induced stabilization of a secondary structure in a RNA. The 5’ end of the HCV RNA 
genome exhibits an hairpin that is stabilized by miR122, expressed in hepatocytes. The binding of miR122 is 
necessary at two sites to maintain the natural viral life cycle (Machlin et al, 2010).  
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The repression of the translation may occur at the initiation step. In this case the miRISC 
complex is assumed to interfere with the 5’ cap and/or with initiation factors or even with the 
great ribosomal subunit, impairing its binding with the small one. Repression of the translation 
may also occur during elongation. In this case, the mechanism could involve a drop of the 
ribosome from the mRNA, a blocking of the ribosome or the proteolysis of the nascent protein. 
These three mechanisms are assumed to be specific to some genes and not widespread 
(Stroynowska-Czerwinska et al., 2014). 
The other widespread mechanism is the launching of the deadenylation of the target by the 
miRISC complex, leading the target to be degraded. This mechanism is more described than 
the previous ones (Wahle and Winkler, 2013) and relies on TNRC6 (Trinucleotide Repeat-
Containing gene 6 protein), a protein of the miRISC complex. TNRC6 establishes first the 
interaction between miRISC and PABP and next, it recruits the PAN2-PAN3 (Poly-A 
Nucleases) complex that deadenylates the poly-A tail of the mRNA. TNRC6 is also able to 
recruit the CCR4-NOT complex through an interaction with the TOB protein to deadenylate 
the mRNA thanks to another pathway. Next to this deadenylation, the transcript is usually 
degraded into P bodies which are non-membranous organelles with a high concentration of the 
mRNA-turnover proteins (Stroynowska-Czerwinska et al., 2014). 
Degradation 
Like the other types of RNAs, miRNA are submitted to a permanent turnover but the 
mechanism is still poorly understood. The Tudor-Staphylococcal/micrococcal-like Nuclease 
(TSN), which harbors an endonuclease activity, endorses the role of degrading miRNA in the 
Tudor-mediated miRNA decay (TumiD) pathway. To exert this effect, the miRNA is first 
detached from its target by Upf1 thanks to its helicase activity (Elbarbary et al., 2017a, 2017b). 
Upregulation of the gene expression mediated by miRNAs 
Several examples of upregulation by miRNAs have been described. It can directly impact the 
gene expression at three different steps : during transcription, at the post-transcription level or 
during translation. For instance, a small activator RNA (saRNA) is recruited by an Ago protein 
and targets a promoter directly within the nucleus (Matsui et al., 2013). The interaction between 
Ago, the miR, the promoter and the RNAPII regulates transcription either positively or 
negatively. saRNAs differ from miRNAs only by their function. The precise mechanism is still 
not known but seems to involve transcription factors, differential methylation of the promoter 
and remodeling of the chromatin structure (Huang, 2017; Setten et al., 2018). 
Another upregulation by a miR has been described by Ma et al (Ma et al., 2010) (Figure 5). 
Tristetraprolin (TTP) is a human RNA-binding protein that recruits mRNA decay machinery 
when bound to an ARE (AU-rich element). This interaction leads to the decay of IL-10 mRNA 
in an in vitro culture of human macrophages. However, when miR466l binds to the transcript, 
it competitively antagonizes the binding of TTP and stabilizes the mRNA (Ma et al., 2010). 
In hepatitis C virus (HCV), a mechanism has been shown to upregulate viral abundance and 
translation of viral proteins. The virus, in order to stabilize its 5’ terminal nucleotides, recruits 
two molecules of a liver-specific miRNA, miR-122. These two molecules form an oligomeric 
structural complex that stabilizes the genome of the virus by inhibiting the action of Xrn-1 on 
the viral RNA (Figure 6). The interaction between two miRNA and the 5’ end of the viral 
genome also enhances the potency of an IRES, which increases the translation of the viral 
protein (Machlin et al., 2011). 
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1.3) Marek’s Disease Virus 
DNA viruses are a good way to study a lot of cellular mechanisms. They are especially a good 
model to study specific transcriptional mechanisms. They are proven to express miRNAs, 
mRNAs with alternative transcripts, and they have an easy-to-study genome, big enough to 
express a large series of transcripts and small enough to easily identify them.  Gallid 
Herpesvirus 2 is a good way to enter herpesviruses biology since chicken is a cheap ethical 
model and since all the resources to study the virus are available to work both in vitro and in 
vivo (Boumart et al., 2018; Muylkens et al., 2010; Rasschaert and Laurent, 2015; Strassheim et 
al., 2016). 
1.3.1) Background information 
Gallid Herpesvirus 2 (GaHV-2), also known as Marek’s Disease Virus (MDV), is an 
alphaherpesvirus that is the causative agent of Marek’s Disease (MD), first described by József 
Marek in 1907. The very first characterization of the symptoms of the disease described a 
polyneuritis syndrome with low mortality. In the 1960’s, the post-war industrialization 
promoted intensive poultry industry. Concomitant with this period, the virus became 
increasingly virulent until an acute form of MD was discovered to induce visceral tumors, 
killing up to 30% of the infected fowls. This increasing death rate made GaHV-2 a burden for 
poultry industry. This lead to the development of attenuated vaccine strains (Figure 8) (Gennart 
and Muylkens, 2018). 
Today, GaHV-2 is used as a relevant model for herpesvirus infections and virus-induced 
lymphomas. More precisely, the hyper virulent strain of the virus (RB1B), which is used in this 
master thesis, leads to immunosuppression, neurological paralysis and death in the susceptible 
chicken in a couple of weeks. This allows to have a fast, ethical and cheap insight into the 
disease (Boumart, 2018). 
GaHV-2 has a particular genomic organization, the double stranded DNA genome is made of 
two segments each surrounded by inverted repeats (Figure 7). The first part is composed by 
TRL (Terminal Repeat Long), UL (Unique Long) and IRL (Internal Repeat Long). The second 
part, which is shorter, is made of IRS (Internal Repeat Short), US (Unique Short) and TRS 
(Terminal Repeat Short). Based on this genome organization, GaHV-2 displays the same 
genomic arrangement as alphaherpesviruses infecting human such as Human Herpesvirus 1 and 
2 (HHV-1 and HHV-2) (McPherson and Delany, 2016). 
1.3.2) Viral cycle 
The viral cycle is divided in four phases that are highly regulated on their gene expression 
pattern (Figure 9). Two productive phases are separated by the latency from which lymphocytes 
are transformed due to viral infection. This fourth phase takes place in the latently infected T 
lymphocytes, which then spread within the organism, forming the virus-induced lymphomas 
within the peripheral nerves and visceral organs (Davison and Nair, 2004). 
The early productive phase starts with the infection of the chickens. The virions are found in 
the dust present in the environment of the naive chickens. Infected particles are inhaled by the 
animal and the Antigen-Presenting Cells (APC) become infected by the virions through the 
lung epithelium. 24 hours later, the virus is present in the primary lymphoid organs, invading 
B and T lymphocytes thanks to cell-to-cell contacts (Bertzbach et al., 2018; McPherson and 
Delany, 2016). 
Latency is established 7 days post-infection (dpi) mainly within CD4+ T lymphocytes. The 
genome of GaHV-2 is integrated within host telomeres which ensures the maintenance of the 
viral genome by the infected cell and it shelters the virus from the immune system while it is 
disseminating within the organism (Boodhoo et al., 2016; Kheimar et al., 2017). The integration  
 Figure 8 : Evolution of the pathogenecity of GaHV-2 over time, next to vaccination against the disease. Pathotypes 
are designated as follow : m = mild ; v = virulent ; vv = hypervirulent ; vv+ = hypervirulent +. RB1B, the strain 
used during this master thesis is a vv+ strain (Dambrine et al, 2016). 
 
 
Figure 9 : Viral life cycle of GaHV-2 during a natural infection. Day 0 (D0) represent the moment when the 
chicken became infected by inhalation of dust containing viral particles. The days were counted in an artificial 
model of infection (natural way is slower). The grey arrows represent reactivation and the dark grey ellipses 
represent the production of lymphoma from transformed latently infected T cells (Gennart et al, 2015). 
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is needed for the virus to keep efficient transformation and reactivation rate (Kaufer et al., 
2011). 
Around 14 dpi, the latently infected lymphocytes reactivate, leaving latency and starting the 
late productive phase. Virus then replicates within the whole organism at high rate, especially 
within the feather follicles. The shedding of feathers from the infected fowls releases virions in 
the surrounding environment. It is therefore associated with dust that can be inhaled by the 
naïve chickens that become infected (Boodhoo et al., 2016; Gennart et al., 2015). 
1.3.3) Major viral genes 
Viral genome encodes at least 103 identified proteins which are, for most of them, common to 
the other alphaherpesviruses. More than just being common, some genes are collinear between 
the alphaherpesviruses. The majority of these genes encode core proteins and are located in the 
unique regions of the genome. In the subsequent paragraphs, some genes considered as “major”, 
following their involvement in the pathogenicity of the disease or in the viral life cycle, are 
depicted. These genes are embedded mostly in the repeated regions and are often specific to the 
pathotype and the gender of the virus (Davison, 2002). 
1.3.3.1) Meq 
Meq (MDV EcoRI Q fragment) is the major oncogene of the virus and is encoded from the 
gene meq located in the repeated regions surrounding the UL segment of the genome. This 
protein is expressed during all the phases of the viral life cycle and was early discovered to have 
oncogenic properties since it shares properties with some of the cellular proto-oncogenes. 
Actually, its N-terminal domain is a b-ZIP (basic leucine zipper) similar to the one carried by 
the Jun/Fos proto-oncoproteins. Concerning its C-terminal domain, it encompasses a proline-
rich region, similar with WT-1 which is a tumor suppressor, with a transactivation role (Gennart 
et al., 2015; Kung et al., 2001; Qian et al., 1995). 
Meq mainly acts as a transcription factor integrated to the cellular transcriptional network. 
Thanks to its b-ZIP domain, it can dimerize with either itself or another b-ZIP-containing 
protein, such as Jun for which it has a strong affinity. It also has affinity for some other cellular 
factors, such as cAMP response element binding protein (CREB), p53, pRB,… All these factors 
are either proto-oncogenes or tumor suppressor (Kung et al., 2001; Qian et al., 1995). 
According to the factor bound to Meq, the complex acquires affinity for specific nucleotide 
sequences. Two major Meq Response Elements (MERE) exist within the genomes of both the 
virus and the host. MERE-1 is targeted by the Meq/Jun heterodimer meanwhile MERE-2 is 
targeted by the Meq/Meq homodimer (Kung et al., 2001; Qian et al., 1995). 
The binding of the heterodimer Meq/Jun to a MERE-1 site transactivates genes that are related 
to cellular transformation and viral replication, such as Bcl-2 and ICP4 respectively. The 
MERE-2 sites are related to a decrease of gene expression. For example, the bidirectional 
promoter linked to pp38/pp24 and 1,8kb family of genes is repressed by the Meq/Meq 
homodimer. These genes are late lytic and thus, Meq prevents viral DNA replication and 
productive infection (Gennart et al., 2015; Qian et al., 1995). 
1.3.3.2) vTR 
The genome of GaHV-2 exhibits the same telomeric repeats (TMR) than the chicken 
(TTAGGGn) at its ends. These TMR are dispensable for virus growth in vitro but not in vivo. 
Actually, the absence of TMR considerably reduces the incidence of the disease and its 
oncogenecity. Moreover, the deletant mutants are less able to integrate the host genome and to 
reactivate next to this (Kaufer et al., 2011). 
  
 Figure 10 : Secondary structure of the vTR of GaHV-2. A highlight was put on the homologies between vTR 
and chTR represented as CR (Conserved Regions) domains (Kheimar et al, 2017). 
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Since the virus maintains itself within the telomeres, it is threatened by telomeres shortening. 
The virus evolved to discard this threat and therefore induces the cellular telomerase reverse 
transcriptase (TERT) by providing the RNA subunit that is essential for its activity. The virus 
genome encodes a viral telomerase RNA subunit (vTR) that shares 88% of its sequence with 
the chicken one (chTR). The conserved domain show a highly structured secondary 
conformation that display an even higher homology with chTR (Figure 10). vTR is present in 
two copies in both the TRL and IRL regions of the genome (Kheimar et al., 2017). 
As well as TMR, vTR is involved during transformation of GaHV-2-infected cells. Mutations 
in several parts of its sequence severely alter the transformation rate of the GaHV-2-infected 
cells (Trapp et al., 2006). On the opposite, the overexpression of vTR leads to an increasing of 
the proliferation and the expression of adhesion factors (Kheimar et al., 2017). 
1.3.3.3) pp38 and pp24 
A bidirectional promoter is located within the repeats surrounding the UL segment of the viral 
genome near the UL region. This bidirectional promoter controls the transcription of the 14kDa 
proteins associated transcripts and, in the opposite sense, of both pp24 and pp38 
phosphoproteins. More precisely, pp24 gene overlaps the TRL and UL meanwhile pp38 overlaps 
IRL and UL (Boumart, 2018). 
These two proteins, similar in their NH2-terminal ends, assemble to form a heterodimer 
pp24/pp38 which transactivates its own promoter (Boumart, 2018). However the precise role 
of pp38 alone is still under debate. At first, pp38 was thought to be needed to maintain the 
transformation state of the lymphocytes (Xie et al., 1996) but a recent study did not show any 
impact on the maintenance of the transformed state of the infected cells (Zhang et al., 2019).  
Nevertheless, pp38 was shown to interfere with apoptosis through an increase of mitochondrial 
succinate dehydrogenase. Since pp38 does not interact with the mitochondria, the precise 
mechanism is still under investigation (Piepenbrink et al., 2009). 
1.3.3.4) vIL-8 
During the viral cycle, the virions do not locate within the bloodstream anytime. The only way 
used by the virus to spread is by cell-to-cell contacts. During this process, it is of first 
importance to establish close contacts between infected and non-infected cells. The role of the 
viral InterLeukin 8 (vIL-8) is to insure these contacts (Haertle et al., 2017). 
vIL-8 is a CXC chemokine homolog to the chicken CXCL13 present in two copies of the viral 
genome, in the long repeated regions. It acts as a chemoattractant for several cell types. Notably, 
B and T lymphocytes are reached by the virus in a vIL-8-dependent manner (Haertle et al., 
2017). 
1.3.3.5) LATs 
Latency Associated Transcripts are a series of long non-coding RNAs (lncRNA) transcribed 
from the IRS and TRS regions. Although the global function of these lncRNA is known to insure 
the latency of the virus in the infected cells, the precise mechanism still has to be described 
(Boumart, 2018; Rasschaert et al., 2016). 
The diversity in the transcripts and their splicing pattern could make their functions as much 
diverse. The transcription results in at least 22 transcripts encompassing from 3 to 15 exons. 
The first intron of the sequence encodes microRNAs that are known to inhibit both cellular and 
viral transcripts. This mechanism maintains latency within the infected cells and prevents 
detection by the immune system. The second specificity of these transcripts is their location 
which is antisense to ICP4 (see next point) in the genome of GaHV-2 but the LAT-encoding  
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gene is longer both upstream and downstream ICP4. Thus, the role of the LATs could be related 
to the function of ICP4 (Boumart, 2018; Rasschaert and Laurent, 2015; Rasschaert et al., 2016). 
1.3.3.6) miRNAs 
Expression of viral miRNAs is a common feature among herpesviruses. 25 miRNAs from 13 
premiRNAs have been shown to be expressed by GaHV-2 during the infection. They are 
gathered in three clusters. MDV-miR-M4 (miR-4) is encoded from the first cluster, also known 
as Meq-cluster because it is located upstream of the Meq oncogene, with 5 other miRNAs. The 
second cluster is named Mid-cluster and is located downstream of Meq. It encodes three pre-
miRNAs. The third one, the LAT-cluster is located in the first intron of the LAT and encodes 
5 miRNAs (Muylkens et al., 2010; Zhuang et al., 2017). 
Viral miRNAs are widely studied for their involvement in the viral pathogenesis. Actually, they 
take part in the fine tuning of the gene expression, allowing the virus to keep a balance between 
immune evasion and spreading within the organism. Some of them regulate the transition to the 
late productive phase by targeting immediate early genes, other can also target the late genes 
and regulate the level of productive replication within the infected cells (Muylkens et al., 2010). 
1.3.3.7) MDV-miR-M4 
miR-4 is known as a multi-functional miRNA. Both host and viral transcripts have been 
identified as targets of miR-4. One strand of the premiRNA (mdv-miR-M4-5p), which is the 
most expressed one, shares its seed sequence with gga-miR-155, its cellular ortholog. Thus, it 
downregulates the same set of cellular targets, having an effect on transcription factors, 
apoptosis signaling, cell differentiation, innate immunity and oncogenesis (Zhuang et al., 
2017). Viral mutants deleted for the miR-4 locus were produced and tested in vitro and in vivo. 
Despite its multi-functional aspect on cell cycle, deletion mutants did not show severe 
impairments on viral replication. However, these mutants lost their oncogenecity (Zhuang et 
al., 2017). The effect of premiR-4 on viral transcripts have been characterized and showed 
interference with UL28 and UL32 expression (Muylkens et al., 2010). These proteins are not 
characterized in GaHV-2 yet but they are essential factors needed for the cleavage and 
packaging processes in herpesviruses. A match was also found within the bicistronic transcript 
ICP22-US10. Precisely, the seed sequence of MDV-miR-M4-5p covers 7 nucleotides of the 
ICP22 open reading frame (ORF) including the stop codon. This sequence match was 
unexpectedly shown to increase the amount of ICP22-US10 bicistronic transcript and was 
shown to “turn on” the expression of the ICP22 protein (Boumart et al., 2018). 
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1.4) ICP’s 
Infected-Cell Proteins (ICP’s) are a group of immediate early (IE) proteins involved either 
directly or indirectly in transactivation of viral genes. In Alphaherpesviruses, 7 ICP’s are 
described. However, only five of them are present in the GaHV-2 genome and four of them are 
characterized since ICP0 encoded protein has not been identified yet (Boumart, 2018; Previdelli 
et al., 2019). 
1.4.1) ICP4 
ICP4 is an IE protein specific of the alphaherpesviruses. It is the major transactivator of the 
productive phase of the viral cycle. Within the alphaherpesviruses, the global identity rate for 
ICP4 is around 30% but some conserved domains share up to 55% of their genic identity. They 
are highly phosphorylated proteins which modify their localization and activity (Rasschaert and 
Laurent, 2015).  
ICP4 of GaHV-2 is poorly expressed from the repeated regions surrounding US during latency. 
Its expression is extracellular at first and finally leads to reactivation (Rasschaert and Laurent, 
2015). During the reactivation and the productive phase, the expression of ICP4 is increased. 
During reactivation, it localizes in the cytoplasm. During the fully-productive phase, ICP4 
seems to localize shortly in the center of the nucleus and then, it relocalizes at the border, at the 
nuclear membrane (Boumart, 2018; Rasschaert and Laurent, 2015). 
The most conserved domains are the 2nd and the 4th ones. The 2nd corresponds to the N-terminal 
domain of the protein, which allows targeting specific promoters and to multimerize. The 4th, 
with the 5th, corresponds to the C-terminal domain, which transactivates the genes by binding 
to promoter sequences and increases the recruitment of the RNA pol II (Rasschaert and Laurent, 
2015). 
Nevertheless, ICP4 has also a repressing function. The most characterized target for this 
repression is the negative feedback of ICP4 on its own promoter. In this case, ICP4 has a highly 
specific target ATCGT which make it a competitive inhibitor against the other transactivators 
(DeLuca, 2011; Rasschaert and Laurent, 2015). 
The last role of ICP4, which has still to be fully described, is its involvement in the latency. 
ICP4 depletion triggers the apoptosis of GaHV-2-infected cells (Rasschaert and Laurent, 2015). 
As the major transactivator protein encoded by the virus, ICP4 is tightly linked to several 
prominent viral genes. First, the LATs gene is antisense to ICP4. Their expression are 
negatively correlated. The LATs are assumed to have a negative effect on ICP4 to maintain 
latency. Next, a direct interaction of ICP4 with the pp38 promoter has been shown. There is 
also a link with Meq since there is a functional MERE-1 site within the ICP4 promoter. Finally, 
the protein is also regulated by the viral miRNAs, especially MDV-miR-M7 (Strassheim et al., 
2012). 
1.4.2) ICP27 
ICP27 is the only ICP that has been identified in every Herpesviridae. In GaHV-2, it is collinear 
with the gK protein (UL53) in the UL part of the genome. This collinearity leads to two types 
of transcripts encoding the protein. The first one is transcribed from the gK promoter to build a 
bicistronic transcript encompassing both gK and ICP27. The second one, shorter, is made 
thanks to the ICP27 promoter, building a monocistronic transcript. These two promoters allow 
to monitor the expression pattern of the both genes. Actually, the gK promoter seems to be a 
hybrid promoter, which allows it to be active during the whole viral cycle since the ICP27 
promoter is a canonical IE promoter only active during the lytic phase. However, gK is a L gene 
and ICP27 has a specific expression pattern (see further). Thus, according to the phase of the  
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viral cycle, the splicing of the pre-messenger RNA (pre-mRNA) regulates the expression 
pattern of the proteins (Strassheim et al., 2016). 
The splicing of the transcript encoded from the gK promoter can lead to the productive of either 
gK during the late productive phase or an alternative truncated version of the ICP27 protein 
during latency. How much the function of the protein is altered is not known and is hard to 
predict since the deleted part of the protein is the least conserved. Otherwise, when the 
expression of ICP27 relies on the more proximal promoter, the full sequence of ICP27 is 
expressed during the productive phase, like the other IE genes (Strassheim et al., 2016).   
The full-length ICP27 is made of several domains conserved or not among the herpesviruses. 
The most conserved domain is the homolog of the well-known UL69 superfamily. It is a folded 
domain which allows ICP27 to form complex with other proteins, including transcription 
factors or self-association (Tunnicliffe et al., 2018). The two other conserved domains are the 
Nuclear Localization Signal (NLS) and the binding site for cellular factors like the Nuclear 
Export Factor (NXF1) (Amor et al., 2011; Ote et al., 2009; Strassheim et al., 2016). 
The functions of the full-length ICP27 are multiple and were precisely characterized, especially 
in HHV-1. Like the other ICP’s of GaHV-2, most of its functions are related to the 
transcriptional and post-transcriptional regulation of the viral genes (Amor et al., 2011; 
Strassheim et al., 2016). 
First, ICP27 is able to inhibit the pre-mRNA splicing by the spliceosome. Shortly, ICP27 binds 
to some splicing factors, for example SRp20 during HHV-1 infection, and stall the spliceosome 
factors at the splicing site in a “pre-spliceosomal” stage. Until now, it has been thought that this 
function could contribute to the shutoff of the cellular genes without affecting the viral genes 
that do not need any splicing for their expression. ICP27 is also interacting with SRPK, which 
is a kinase that phosphorylate the splicing factors, inhibiting its activity (Sandri-Goldin, 2008). 
During the infection by GaHV-2, only the first function described has been reported, inducing 
coalescence of the splicing factors in the nucleus and inhibiting the splicing. 
Second, ICP27 has a role of transactivation by interacting with other transactivation proteins 
like ICP4. In HHV-1, ICP27 binds and stimulates RNA polymerase II (RNAPII). However, the 
binding of ICP27 to RNAPII could be due to a third unknown protein (Sandri-Goldin, 2008). 
Third, ICP27 regulates the nuclear export of some proteins. Thanks to its NXF1 domain, it 
binds to export factors and, through a binding to the target protein, it takes the NXF1-dependent 
proteins out the nucleus (Ote et al., 2009). 
Finally, ICP27 also has a potential translational role. In several herpesviruses, ICP27 is able to 
bind to the translational machinery and monitor its activity. Notably, it has been shown to bind 
to the poly-A-binding protein (PABP) which is correlated with the inhibition of the nonsense-
mediated mRNA decay (NMD) and with the initiation of the translation through interaction 
with collateral initiation factors (Fontaine-Rodriguez et al., 2004). 
1.4.3) ICP0 
RLORF-1 is a putative ICP0 homolog in GaHV-2. This protein can switch on viral expression  
and trigger the reactivation from latent HHV-1 infection (Samrat et al., 2017). However, in 
GaHV-2, a tagged protein was not revealed on a western blot and the phenotype of the infected 
cells was not affected. It seems that ICP0 is not expressed in GaHV-2 (Bertzbach et al., 2019). 
1.4.4) ICP8 
Already characterized in HHV-1, ICP8 has been shown to be linked with the integration and 
the replication of the herpesviruses. By its ability to bind to ssDNA, ICP8 cooperates with UL9 
 Figure 11 : Localization of ICP22 on a genomic and transcript level. ICP22 is transcribed from the US region 
of the genome. The transcription leads to two types of transcript : a monocistronic transcript encompassing only 
ICP22 (5% of the cases) polyadenylated thanks to an alternative poly-A signal (APAS) or a bicistronic transcript 
encompassing both ICP22 and US10 genes (95% of the cases) polyadenylated thanks to a canonical PAS. Three 
miRNA were shown to regulate the transcript encoding for ICP22: MDV-miR-M5; MDV-miR-M1 and MDV-
miR-M4. 
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and UL12 to permit the recombination. During this mechanism, UL9 first opens the origin of 
replication. Next UL12 degrades one DNA strand of the virus. And then ICP8 binds to both the 
overhanging strand and the origin of replication. Self-interaction between the ICP8 proteins 
allow to get both these parts closer, increasing thereby the recombination mechanism 
(Weerasooriya et al., 2019).  
UL12 and ICP8, considered as a recombination complex, are also present in GaHV-2 and both 
are essential for the viral replication. Their roles seem to be the same as in an infection by HHV-
1 but the precise mechanism still has to be clarified (Previdelli et al., 2019). 
1.4.5) ICP22 
ICP22 is found in most of the alphaherpesviruses, it is only absent in iltoviruses (Chandra et 
al., 2012). In the GaHV-2 genome. It is encoded from the US1 gene at the 5’ end of the US 
region (Figure 11). Interestingly, like ICP27 and gK, ICP22 is expressed from a bicistronic 
transcript gathering ICP22 and US10. Actually, 95% of the transcripts are bicistronic, ending 
by a poly-A tail after US10 thanks to a canonical polyadenylation signal (PAS), AATAAA. A 
non-canonical signal, ATTAAA, is found between both ORF of ICP22 and US10 and leads to 
the polyadenylation of 5% of the transcripts (Boumart et al., 2018).  
Unlike the other ICP’s expressed during a GaHV-2 infection, ICP22 has been characterized as 
an L gene expressed during the productive phase. During this phase, ICP22 is localized within 
the cytoplasm of the infected cells (Boumart et al., 2018). 
The gene encodes a protein made of 179 amino acids (aa) with a molecular weight of 29kDa 
when it is non-phosphorylated. This size includes a conserved Herpes_IE68 domain which 
confirm its homology with other IE proteins, especially the homology with the ICP22 encoded 
by other alphaherpesviruses (Boumart, 2018). 
ICP22 has been shown to be important in maintaining the replication during progression of 
Marek’s disease. Nevertheless, it does not affect either lymphoma formation in vivo or viral 
reactivation and its precise functions are still largely unknown (Parcells et al., 1995). In Human 
Herpesvirus 1 and 3 (HHV-1 and HHV-3), it has a role in inhibiting the transcription by 
dephosphorylating the second Serin of the RNAP II. This inhibition is counterbalanced by VP16 
which binds to the viral promoters and triggers the transcription of target genes. During an 
infection with HHV-1, interactions have been shown with pTEFwhich is involved in the 
dephosphorylation of the great subunit of the RNAP II (Zaborowska et al., 2014). 
In GaHV-2, a luciferase assay on several viral promoters showed the same effect in inhibiting 
the transcription. However, in this case, ICP22 remains within the cytoplasm and does not 
possess any nuclear localization signal (NLS). Thus, the precise mechanism of its activity 
remains to be elucidated (Boumart et al., 2018). ICP22 could therefore be translocated by 
binding to a cellular or an unknown viral protein before or after phosphorylation. 
The last role of ICP22, not shown in GaHV-2 but in HHV-1, is its link with the cellular life 
cycle. Actually, cells infected by HHV-1 produce less cyclines A and B and cdk1. It results in 
the blocking of the cell in the S phase of its life cycle which increases viral replication 
(Zaborowska et al., 2014). The drop in viral replication in an ICP22-deletant-virus could be 
explained by this function of ICP22 but it still has to be described. 
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1.5) Objectives 
Studying gene expression is essential in understanding the life cycle of GaHV-2, a virus that is 
considered as a major threat for the poultry industry. More precisely, regulating processes 
governing the gene expression is a prerequisite for depicting the life cycle of this virus that is 
lethal after a few weeks by inducing CD4+ T cell lymphoma. A hallmark of cancer is the 
decrease of the tumor suppressors concomitant with the increase of the proto-oncogenic factors. 
How GaHV-2 is able to tightly regulate its gene expression, for 1) invading the host ; 2) 
escaping the immune system; 3) producing lymphoma and 4) spread quickly in the organism 
before the death of the animal, is far from being fully described. Several genetic regulating 
mechanisms of GaHV-2 are already characterized, such as bidirectional promoters 
(pp38/pp24), bicistronic transcripts (ICP27-gK), alternative transcripts (LATs), and viral 
encoded miRNA produced from spliced transcripts. 
GaHV-2 encoded miRNAs are potent negative regulators of both viral and cellular genes. 
Numerous studies have shown these noncoding RNAs involved in the switch between 
productive and latent phases of the infection by inhibiting the translation of viral genes 
supporting the early and late productive phases. Regarding cellular genes targeted by GaHV-2 
miRNAs, several reports have shown that viral miRNAs are involved in the cellular 
transformation by downregulating a large set of genes controlling the cell proliferation. Thus, 
the GaHV-2 miRNAs are known as negative regulator of the gene expression fine tuning several 
processes underlying the progression of both the viral and the cellular cycles. No miRNA-
induced activation was really deciphered up to now. Knowing the miRNA necessity during 
latency and the high diversity of the described roles attributed to miRNA, this fact could be 
surprising. 
Recently, Boumart and collaborators (Boumart et al., 2018) described a bicistronic transcript 
encompassing the ICP22 and US10 ORF. This peculiar transcript was shown to be targeted by 
three miRNAs. One of them, miR4, was unexpectedly shown to increase the amount of 
bicistronic transcript and was shown to “turn on” the expression of the ICP22 protein. It is still 
not known when miR4 binds to its target to enhance gene expression, neither how it happens. 
The main goal of this project is to elucidate the whole pathway that triggers the upregulation of 
the expression mediated by a miRNA targeting a bicistronic transcript. This study aims at 
investigating the different functional parts of the whole transcript that might be involved in the 
upregulation triggered through miRNA-mRNA interactions. First the whole transcript will be 
analyzed thanks to bioinformatics. Primary or secondary RNA structures might explain the 
recruitment of proteins impairing the translation of the bicistronic transcript. This part of the 
project aimed at localizing these potential RNA structures. From this in silico analysis, the main 
working hypothesis will be addressed through the following questions : (1) Do specific RNA 
motifs have an impact on the translation of both ORF localized in the bicistronic transcript? (2) 
Is it possible to interfere with these motifs through miRNA-mRNA interaction?  
Answering these questions might open a gate to a new RNA-mediated pathway of gene 
expression and think outside the box of the so-called “central dogma”. To investigate these 
questions a reporter system will first be built by replacing both ORF of the bicistronic transcript 
with fluorescent reporter. These reporters will be used to monitor the expression of the genes 
both in the presence and in the absence of miRNA expression. Next to this, the half-life of the 
transcripts will be measured both in the presence and in the absence of miRNA expression. 
  
Table 1 : List of primers used following the construction needed. The small letters represent a tail added to our 
primers to bind with the restriction enzymes to the constructs. The italic letters represent the restriction sites. The 
capital letters represent the sequence matching with the full sequence. 
Constructi
ons 
Bording primers Fwd/Rev Overlap primers Rev/Fwd 
ICP22-
miRE wt-
pAmut-
US10 
acacgctagcATGAGTCGTGATCGAGATC
GAGC  
GCCGTGTAAGATATATACATATTGGAGAGGTATGG
CC 
acacaagcttCGAAGTAATCCTCATGCAT
ACCCCA 
TCCAATATGTATATATCTTACACGGCGCTCGTCTC
CAG 
GFP- 
miREwt-
US10 
acacgctagcATGGTGAGCAAGGGCGAG
GAGCT 
GCAATTTACTGTCTACCGACAACTTGTACAGCTCG
TCC 
acacaagcttCGAAGTAATCCTCATGCAT
ACCCCA 
CGAGCTGTACAAGTTGTCGGTAGACAGTAAATTGC 
GFP-
miREmut-
US10  
acacgctagcATGGTGAGCAAGGGCGAG
GAGCT 
GGATAGTTAGATTATATCACTGTCTACCGACAACT
TGTAC 
acacaagcttCGAAGTAATCCTCATGCAT
ACCCCA 
CGGTAGACAGTGATATAATCTAACTATCCAGACTT
GAAGAG 
GFP-UTR acacgctagcATGGTGAGCAAGGGCGAG
GAGCT 
GCGATTAGTTACTTGTACAGCTCGTCCATGCCGAG 
acacaagcttCGAAGTAATCCTCATGCAT
ACCCCA 
GGACGAGCTGTACAAGTAACTAATCGCACAATTAT
TAATAGG 
ICP22-
miREwt-
GFP 
acacgctagcATGAGTCGTGATCGAGATC
GAGC 
GCTCACCATACCTCTCCAATATGTATATATCTTAC
ACG 
acacaagcttCGAAGTAATCCTCATGCAT
ACCCCA 
CATATTGGAGAGGTATGGTGAGCAAGGGCGAGG 
ICP22-
miREmut-
GFP 
acacgctagcATGAGTCGTGATCGAGATC
GAGC 
GGATAGTTAGATTATATCACTGTCTACCGACAAAT
CGTTC 
acacaagcttCGAAGTAATCCTCATGCAT
ACCCCA 
CGGTAGACAGTGATATAATCTAACTATCCAGACTT
GAAGAG 
GFP-hp-
miREwt-
US10 
acacgctagcATGGTGAGCAAGGGCGAG
GAGCT 
GAAATAGTTCCCGACTTGTACAGCTCGTCCATGCC
G 
acacaagcttCGAAGTAATCCTCATGCAT
ACCCCA 
GCTGTACAAGTCGGGAACTATTTCTTCAGACTGCG 
GFP-hp-
miREmut-
US10 
acacgctagcATGGTGAGCAAGGGCGAG
GAGCT 
GAAATAGTTCCCGACTTGTACAGCTCGTCCATGCC
G 
acacaagcttCGAAGTAATCCTCATGCAT
ACCCCA 
GCTGTACAAGTCGGGAACTATTTCTTCAGACTGCG 
qPCR-
ICP22 
CAACTGCCACATTCACATCCG  
GCACATAACCGAGCGACATCG  
qPCR-GFP CTACGGCAAGCTGACCCTGAAG  
GTCGTGCTGCTTCATGTGGTCG  
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2) Material and methods 
2.1) Viral and bacterial strains 
The very virulent strain of the GaHV-2 virus, RB1B (GenBank EF523390.1), is used for this 
research. This strain of the virus was isolated in the early 1980’s, when it displayed resistance 
against immunity induced by SB-1 and HVT vaccine strains (Schat et al., 1982). 
The TG1 bacterial strain of E.coli was used to perform the amplification of the plasmids. These 
bacteria were made competent by a homemade treatment. A preculture was grown overnight in 
10mL of LB medium at 37°C and put into 1L of 2YT medium. The main culture was grown 
until the optic density (600nm of wavelength) of the medium was at 0,45. The bacteria were 
put on ice during 2 hours before a first centrifugation (5000 rpm – 4°C – 15min). The 
supernatant was removed and the bacteria resuspended in 250mL of MilliQ water before a 
second centrifugation (5000rpm – 4°C – 15min). The supernatant was again removed and the 
bacteria resuspended in 200mL of MilliQ water before a third centrifugation (5000rpm – 4°C – 
15min). This step was again repeated twice. The supernatant was finally removed and the 
bacteria resuspended in 20mL of sterile glycerol (10%) before being centrifugated a last time 
(5000rpm – 4°C – 15min). The supernatant was removed and the bacteria resuspended in 2mL 
of sterile glycerol (10%). The bacteria were then aliquoted 50µL aliquots and frozen at -80°C. 
2.2) Bioinformatic analysis 
ICP22-US10 bicistronic transcript was analyzed using web server of RNA structure ProbKnot 
from Mathews Group© [SOURCE]. This analysis produced a map of the nucleotides 
interactions in the full-length sequence of the ICP22-US10 bicistronic transcript. 
Analysis of the structure of the sequence surrounding the stop codon of each analysed 
bicistronic transcript has been done using web server of RNAfold from University of Vienna 
(Institute for Theoretical Chemistry). 
2.3) Site-directed mutagenesis 
An overlapping PCR is made using at least two primers pairs [Table 1]. These primer pairs 
were designed with the Geneious software from Biomatters© and verified using web server of 
NetPrimer from Premier Biosoft© (http://www.premierbiosoft.com/NetPrimer/AnalyzePrimer 
.jsp). 
The bording primer pairs contain restriction sites to allow the digestion/ligation. Following the 
organization of the plasmid, NheI was chosen for the 5’end and HindIII for the 3’end. The 
overlapping Polymerase Chain Reaction (PCR) was made using Q5 high fidelity enzyme in a 
50µL mix following the manufacturer protocol (New-England Biolabs © (NEB)). It means 
10µL of 5x buffer, 1µL of each primer (10µM), 1µL of dNTPs (total concentration of 20mM ; 
5mM of each nucleotide), from 0.1 to 1ng of DNA depending on its origin (plasmid versus 
genomic) and 0.5µL of the enzyme (2U//µL). This enzyme can add 2000 nucleotides/minute, 
each reaction time was adapted following the length of the produced amplicons. Both the 
dehybridization and the hybridization steps were processed 30 seconds. To combine two 
amplicons in overlapping PCR, initial steps included 5 cycles without primers. The resulting 
overlapping fragment was amplified through 30 cycles with appropriate primers. 
2.4) Digestion of the inserts 
Double digestion were done on the inserts using NheI and HindIII restriction enzymes bought 
in NEB industry. This double digestion was done twice and the digested insert purified using 
Macherey-Nagel (MN) © kit and finally eluted in a 18µL final volume. 
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The first double digestion is done using a 50µL mix containing 5µL of 10x buffer, a maximum 
of insert DNA (1µg mx for plasmid DNA), 20U of each enzyme. For the second double 
digestion, 15U of each enzyme were added to the same mix described at the first step. The 
digestion requires, for each step, a digestion at 37°C during 1h and a denaturation at 8°C during 
20 minutes. 
2.5) Vector preparation 
The same NheI/HindIII digestion as above was done on 20µg of plasmid pcDNA 3.1 (-) 
(Invitrogen©). This plasmid contains resistance gene against ampicillin and neomycin and a 
cytomegalovirus promoter for overexpression of the insert. 
A separation of the restricted components is made on an electrophoresis TAE-agarose (1% 
agarose concentration) gel. The fragments were purified using MN kit and eluted in a final 
volume of 100µL. To avoid self-ligation, the plasmid was dephosphorylated twice using calf 
intestinal alkaline phosphatase (CIP) from NEB and purified using phenol/chloroform 
extraction. A first dephosphorylation is made in a 200µL mix containing 100µL of DNA 
(purified at the previous step), 20µL of 10x buffer and 100U of CIP. The second 
dephosphorylation was done by putting 80U of CIP in the same mix. Each step was realized by 
heating the mix 20 minutes at 37°C, 20 minutes at 56°C and 3 minutes at 4°C. 
2.6) DNA purifications 
Two ways to purify DNA were used. The first one used phenol/chloroform extraction, the 
second one used the MN kit. 
Manufacturer protocol was used for MN purification. This includes a dissolution step for the 
gel in a NTI buffer (200µL of NTI for 100mg of gel), the obtained mix is put on a column from 
the kit for a centrifugation (11000xg-1 min) and a double wash with 675µL NT3, each wash is 
followed by another centrifugation step (1000xg-1min). A last centrifugation step is done to 
dry the column (11000xg-1 min). Finally the elution was done using 18µL of water at 37°C, 
incubated 1 minute on the column before a last centrifugation step (11000xg-1min). 
For the phenol/chloroform extraction, the samples are diluted to obtain an initial volume of 
300µL. 300µL of a phenol:chloroform:isoamylalcohol (24:25:1) mix is added before a 
centrifugation step (15min-13000xg-4°C). Supernatant is added to chloroform:isoamylalcohol 
(49:1) before another centrifugation step (15min-13000xg-4°C). Supernatant is added to a 
solution containing 600µL ethanol (100%) and 100µL sodium acetate (3M). One hour at -80°C 
is then required. A third centrifugation step (20min-14000xg-4°C) allows to recover the pellet. 
This pellet is resuspended in 1mL ethanol (75%) before a fourth centrifugation step (5min-
7500xg-4°C). Supernatant is discarded and pellet is dried at 37°C during 5 minutes before being 
resuspended in 30µL of deionized water. 
2.7) Cloning and screening 
The first construct with a mutated cryptic PAS, was inserted into a pGEM-T easy vector 
(Promega©) by TA-cloning. This vector does not need any digestion step. Bacteria were 
transformed with this plasmid and grown in a LB-agar complemented with ampicillin 
(100µg/mL), Xgal (60µg/mL) and IPTG (40µg/mL) in order to perform a -galactosidase 
screen. The white colonies were next screened by PCR (plasmid-specific primers) and then the 
clones presenting the proper insert were sent to sequencing (Eurofins Genomics©) and grown 
to make a MiniPrep. 
The reporters are cloned into pcDNA 3.1 (-) previously prepared. The pcDNA-transformed 
bacteria are grown on LB-agar medium complemented with ampicillin (100µg/mL) in Petri 
dishes. Colonies are screened by directional PCR, forward primer being insert-specific and  
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reverse primer being plasmid-specific. The clones presenting the proper insert in the proper 
orientation are sent to sequencing (Eurofins Genomics©) and grown to make a MidiPrep. 
Both ligations are made using the same mix adapted for T4 ligase from Promega©. 3µL of 
inserts (maximal concentration) are put with 100ng of plasmid, 5µL of 2x buffer and 1µL of 
enzyme. 
The clones that grew overnight on the plates are screened by PCR using GoTaq enzyme 
(Promega©). Colonies were chosen randomly on the plates to be picked and suspended into 
25µL of PCR mix prepared following the manufacturer protocol. It includes 5µL of 5x buffer, 
0.5µL of dNTPs (20mM), 0.5µL of primers (10µM) and 0.125µL of enzyme (5U/µL). 
2.8) Mini/Midi Prep 
For the MiniPrep, the bacterial clones displaying the proper insert are grown overnight at 37°C 
in 5mL of LB-ampicillin (100µg/mL) to amplify the plasmid. This bacterial culture is used to 
make a MiniPrep with a Qiagen© kit following the manufacturer protocol. It begins by a 
centrifugation of the culture (6800xg-3min-room temperature (RT)). The supernatant is 
discarded and 250µL of resuspension buffer PI are added to resuspend the pellet. The lysis 
reaction is done using 250µL of P2 buffer for a maximum 5 minutes time. The lysis buffer is 
neutralized with 350µL of N3 buffer. A centrifugation (13000rpm-10min-RT) is done and the 
supernatant is put on the spin column furnished in the kit for another centrifugation step 
(13000rpm-1min-RT). The column is washed with 500µL of PB buffer, centrifuged twice to 
discard a maximum of the wash buffer. The elution was done using 50µL of deionized water 
with an incubation time of 1 minute followed by a last centrifugation step (13000rpm-1min-
RT). 
For the MIDI prep, the bacterial clones displaying the proper insert in the proper orientation are 
grown overnight at 37°C in 200mL of LB-ampicillin (100µg/mL) to amplify the plasmid. This 
bacterial culture is used to make a MIDI prep with a MN kit following the manufacturer 
protocol. It begins by a centrifugation of the culture (5000xg-15min-4°C). On ice, the 
supernatant is discarded and 8mL of the resuspension buffer [NOM] are added to resuspend the 
pellet. The lysis reaction is done by adding 8mL of lysis buffer and by mixing the tube gently. 
This step does not exceed a maximum 5 minutes time. The filter of the column and the column 
itself are drown by adding on them 12mL of equilibration buffer (EQU). The lysis reaction is 
neutralized by adding 8mL of neutralization buffer (NEU) and by mixing the tube gently. The 
supernatant of the reaction is put on the filter of the column and then 5mL of EQU buffer are 
added on it. The filter is then removed and a wash is done with 8mL of WASH buffer. Up from 
a 50mL falcon tube are put 5mL of elution buffer (ELU) on the column. The column is 
discarded and 3.5mL of isopropanol are added in the falcon tube. A centrifugation step 
(15000xg-30min-4°C) is used to precipitate the DNA. The supernatant is discarded and the 
pellet is washed with 2mL of ethanol (70%) and a centrifugation (7500xg-15min-4°C). The 
pellet is dried during 10 minutes before being resuspended in deionized water. 
2.9) Cell lines 
2.9.1) ESCDL-1 cell line 
Embryonic Stem Cell Derived Line 1 (ESCDL-1) are a mesenchymal cell-derived lytic 
infection model developed by Vautherot et al., 2017. These cells have some advantages 
compared to chicken embryonic fibroblasts (CEF) that were commonly used until now for 
GaHV-2 lytic infection. They are easy to grow, their phenotype is not altered after a long cell 
culture and a high number of passages.  
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They were cultured in a supplemented Dubelcco’s Modified Eagle Medium (DMEM F12 1:1). 
The supplementation included 10% of Fetal Bovine Serum (FBS); 1% of Penicillin 
Streptomycin (PS), 1% of Non-Essential Amino Acids (NEAA) and 1% of sodium pyruvate. 
The cells were grown in an incubator at 37°C and 5% CO2. The passages were made when cells 
were 85% confluent. 
2.9.2) MSB-1 cell line 
MSB-1 are a latently infected T CD4+ lymphocyte model isolated from a chicken spleen 
lymphoma. They were cultured in a supplemented Roswell Park Memorial Institute medium 
(RPMI). The supplementation includes 10% of FBS, 5% of Chicken Serum (CS), 1% of PS, 
1% of NEAA, 1% of sodium pyruvate and 4-(2-Hydroxyethyl) piperazine-1-ethanesulfonic 
acid (HEPES) 25 mM. The cells are grown in an incubator at 41°C and 5% CO2. The passages 
are made every 2 days to restore a cell density of 1/20. 
2.9.3) DF-1 cell line 
DF-1 are non-infected chicken fibroblasts self-immortalized derived from a chicken embryo. 
Cells were cultured in a DMEM supplemented with 10% FBS. 
2.9.4) CEF 
Chicken embryonic fibroblasts are extracted from 11-days-old chicken embryos. The extraction 
is made after the opening of the egg. The embryo was removed from the egg and put in the Petri 
dish containing PBS. The head of the embryo is cut right after the opening, as well as the wings 
and legs. Then, the organs are removed and only the epithelium is taken apart. The epithelium 
was trypsinized twice and the cells were gathered by two centrifugation (300xg-7min). The 
trash are removed as much as possible between the centrifugations. Next, the cells are 
specifically selected by a primary CEF culture medium. The primary CEF culture medium is a 
DMEM supplemented with 1% FBS, 1% CS and 1% PS. The primary CEFs are cultured over 
weekend and then a secondary culture medium is used. This secondary culture medium is a 
DMEM supplemented with 10% FBS and 1%CS. 
2.10) Transfection 
Two ways were used to transfect chicken cells. The first one, using nucleofection was 
performed using Amaxa Nucleofection kit (Lonza ©) on ESCDL-1 cell line. The cells were 
passed 24 hours before nucleofection and gelatin 2% was applied on 6-wells plates. Two hours 
before nucleofection, 5 x 105 cells/well were seeded on the gelatin and incubated in a DMEM 
medium containing 1% of FBS and 1% of CS, in order to make them grip the plate. 106 
cells/condition were nucleofected in 100µL of Amaxa Nucleofector Solution specific for 
fibroblasts. The program was F-024, specific for fibroblasts. As fast as possible, 500µL of 
medium (1% FBS ; 1%CS) were added on the nucleofected cells. The cells were seeded on the 
plates (with the 5 x 105 cells seeded previously). The medium was changed 24 hours after the 
nucleofection and the cells were checked by fluorescent microscopy. 
The second way of transfection was lipofection and was performed on DF-1 cell line. The cells 
were counted and seeded on 6-wells plates (1 000 000 cells/well) 16 hours before lipofection. 
The DNA was diluted in 400µL of Opti-MEM medium. 10µL of Lipofectamine 2000 were 
used/lipofection and diluted in 400µL of Opti-MEM medium. Both DNA and lipofectamine 
2000 were mixed together during 20 minutes before nucleofection. During this time, the cells 
were washed 3 times with Opti-MEM. The mix (800µL/condition) was applied on the cells 
which were incubated 6 hours after lipofection. The medium was then replaced by a classical 
DMEM medium with 10% of FBS.  
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2.11) Flow Cytometry 
One hour before analysis, the cells were detached from the plates using trypsin EDTA and 
resuspended into PBS. The cytometry was performed using a FACSVerse machine from BD 
Biosciences ©. The system allows to gather single cell data by passing individual cells in front 
of a laser. Detector around the cells measure the light intensity to create different data following 
different parameters : the side scatter (SSC) measure the granulosity of the cells, the forward 
scatter (FSC) measure their size and a GFP (Green Fluorescent Protein) filter measure their 
fluorescence. To detect these parameters, several signal amplificators are used. Signal 
amplification is monitored following the potential of the electrodes. In this case, the FSC 
amplificator was put at 100V, the SSC at 200V and the GFP at 320V. 
2.12) RNA extraction 
RNA extraction was performed using TRIzol extraction 24h post-transfection. At the 
beginning, the cells were either detached from the plate using trypsin-EDTA and pelleted by 
centrifugation (300xg – 7 min) or the TRI reagent was put directly on the cells. 1 mL of TRIzol 
was added for 5 million cells and incubated 5 minutes at RT. 200µL of chloroform were added 
and the tubes incubated during 10 min before a centrifugation (12000xg – 15min – 4°C). The 
aqueous phase, which stands up in the tube was extracted and put in 500µL of isopropanol and 
incubated during 10 min to precipitate the RNA. The tubes were centrifugated (12000xg – 
10min – 4°C ) and the supernatant removed. The pellets were washed with ethanol 70% before 
being centrifugated (7500xg – 10 min – 4°C). The pellet was dried and resuspended into 88µL 
of water to perform a DNase treatment. 
2.13) DNase treatment 
Since a lot of DNA was put into the cells through the transfection, it’s important to carry out a 
DNase treatment to remove every DNA molecule that could interfere with the qPCR. It was 
performed using 10µL of DNase buffer and 2µL of DNase after having passed the samples at 
65°C during 5 min. The DNase reaction spent 20 minutes and followed by a phenol/chloroform 
extraction (see 2.6). 
2.14) Reverse transcription 
Reverse transcription was done using SuperScript III kit from Thermofisher© following the 
manufacturer’s protocol. It was chosen to reverse transcribe 2µg of RNA for each sample. The 
mix was thus containing 3µg of RNA, 1µL of oligodT (0,5µg/µL), 1µL of dNTPs (20mM) and 
ultrapure water up to 13µL. This mix was put at 65°C for 5 minutes and then put at 4°C for 
1min. Then were added 4µL of buffer (5x), 1µL of DTT (0,1M), 1µL of RNase OUT and 1µL 
of SuperScript III enzyme (200U/µL). The reverse transcription was carried out at 50°C for 20 
minutes and the enzyme was denatured at 70°C for 20 more minutes. The samples were used 
for qPCR without further treatment. 
2.15) qPCR 
qPCR were performed using EcoTM Real-Time PCR System with the FastStart SYBR Green 
Master (Sigma Aldrich©) kit. 3 dilutions of the reverse transcribed products were done to carry 
out the qPCR (1/10;1/30;1/90). 2µL of each dilution was put into a mix containing 5µL of 
master mix (2x), 0,8µL of each primer (10µM) and 1,4µL of water. The analysis of the results 
was done using GAPDH to standardize the results. 
2.16) Dactinomycin treatment 
To measure the mRNA half-life, a treatment with actinomycin D (or Dactinomycin) (20µg/mL 
of medium) was applied to the transfected cells. This drug strongly binds to DNA and block the 
progression of the RNAPII, inhibiting the transcription. At each time-point (1h;4h;6h;12h;24h), 
the RNA was extracted using the TRIzol extraction and quantified using RT-qPCR. 
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2.17) Protein extraction 
Protein extraction was carried out 48h post-transfection, using RIPA reagent. The cells were 
pelleted using trypsin-EDTA and centrifugated (300xg – 7min) and put into 50µL of RIPA mix. 
It includes 43,5µL of RIPA solution, 5µL of Triton (10x), 1µL of Complete (50x) and 0,5µL 
of PMSF (100x). This reaction was carried out on ice for 30 minutes. Next, the proteins were 
sonicated 3x1min and then centrifugated (14000 rpm – 15min – 4°C). The proteins were next 
dosed using a MultiSkan EX machine with Pierce reagent from the Thermo Scientific© BCA 
Protein Assay kit. 
2.18) Western blot 
25µg of proteins were put into lanes of a 10% acrylamide gel in the presence of SDS and 
migrated during 2 hours in order to perform an SDS PAGE separation. One lane was attributed 
to the scale dye. The running gel was made of 2,5 mL of acrylamide (37,5:1), 100µL of SDS 
(10%), 2,5 mL of Tris HCl (1,5M – pH 8,8), 4,75 mL of distilled water, 100µL of APS and 
10µL of TEMED. The stacking gel was made of 300µL of acrylamide (same concentration), 
30µL of SDS (10%), 760µL of Tris HCl (0,5M – pH 6,8), 1,875mL of distilled water, 30µL of 
APS and 3µL of TEMED. For the electrophoresis, the running buffer was made of 144,2 g of 
glycine, 30g of Tris, 10g of SDS ans up to 1L of distilled water. The transfer was done on a 
PVDF membrane at 4°C during 1h15. The transfer buffer was composed of 15,25g of Tris, 
43,5g of glycine, 1L of methanol and up to 5L of distilled water. Next to the transfer, the 
membranes were blocked using TBST-BSA buffer. The TBST buffer is made of 500µL of 
Tween20 put into 500mL of TBS. 5% of BSA was put into this solution to have the proper 
blocking buffer. The blocking was carried out during 3h at RT. The primary antibody of HSP90 
is a mouse monocolonal antibody that was provided by abcam©, it was diluted at 1:2500 for 
the experiment. The GFP antibody is a mouse monoclonal antibody that was provided by 
invitrogen©, it was diluted 1:2000 for the experiment. The ICP22 antibody is a rabbit 
monoclonal antibody that was provided by the Tours François Rabelais University, it was 
diluted 1:1000 for the experiment. The primary antibodies were incubated overnight at 4°C. 
Next to the incubation, the membranes were washed 3x10min at RT using a TBST buffer, 
prepared as previously described. The secondary antibody were diluted 1:2000 and put during 
1h at RT. The secondary washing were done 3x15min using the same TBST buffer. The 
membranes were next revealed using the Pierce reagent and the ImageQuant LAS 4000 
machine.  
  
Figure 12 : Bioinformatics 
analysis of the ICP22-US10 
bicistronic transcript. A) 
Structural organization of the 
GaHV-2 genome. It displays two 
unique regions, one short and one 
long. These two unique parts are 
surrounded by inverted repeats 
regions. B) Localization of the 
ICP22-US10 bicistronic 
transcript. The bioinformatics 
analysis revealed 2 relevant 
features in the primary structure 
of the transcript. First, a poly-C 
site and next an ARE overlapping 
the stop codon of the first ORF. C) 
mRNA produced in 95% of the 
case, induced by the canonical 
PAS. D) Prediction of ICP22-
US10 internal interactions. The 
lines represent the probable 
interactions between base pairs. 
Both ICP22 and US10 ORFs are 
indicated. E) Bioinformatics 
analysis of the RNA folding of the 
region surrounding the stop codon 
of ICP22 ORF. The scale, from 
purple to red, indicates the 
increasing probability for an 
interaction to happen following 
the MFE. The target site of miR4 
is shown as well as the position of 
the ICP22 stop codon. 
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3) Results 
3.1) Bioinformatics analysis of the ICP22-US10 bicistronic transcript reveals a strong 
structural hairpin located at the stop codon of the ICP22 ORF 
Previous data indicated that ICP22 is mainly expressed from a bicistronic transcript under the 
regulation of three miRNAs: MDV-miR-M1, MDV-miR-M5 and MDV-miR-M4 (miR4). In 
the case of miR4, the bicistronic transcript was shown to be increased by the miRNA-mRNA 
interaction at a site covering the stop codon of the first ORF of the transcript. To better 
understand the mechanism of expression of the 2 ORFs embedded within this major bicistronic 
transcript, we first analyzed the genetic structure of this peculiar transcript (Figure 12). 
Bioinformatics analysis was carried out to identify candidate motifs involved in any mechanism 
susceptible to trigger a decay pathway. A first structure, right after the stop codon was found to 
be a potential AU-rich element (ARE), this structure, made of 61 nucleotides, has a GC content 
of only 23%. Moreover, this region encompasses a stretch of 19 nucleotides including only A 
and U. A second interesting feature is a polyC stretch made of 8 consecutive C located in the 
intergenic region. Both of these features might recruit proteins that would either trigger the 
degradation of the mRNA or interact with Ago to disturb its endonucleolytic activity.  
Bioinformatics analysis was completed to determine sequence self-complementarities over the 
full length mRNA. The resulting map of complementarities shows multiple interactions all over 
the sequence. We focused on the intergenic region between ICP22 and US10 ORFs. A highly 
structured hairpin was identified. It involved 70 nucleotides upstream the stop codon and 30 
nucleotides downstream. This hairpin might hamper the progression of the ribosome through 
the mRNA. Moreover, this hairpin is likely to act as a platform recruiting proteins involved in 
the mRNA degradation. This structure surrounding the ICP22 stop codon could be the key for 
the upregulation involving MDV-miR-M4. 
To support this hypothesis, a region showing weaker interaction and covering 15 nucleotides 
was identified around the stop codon. This stretch of nucleotides corresponds to the target site 
of miR-4. This makes the sequence reachable by the miRISC complex. Interactions with the 
miRNA may trigger a dehybridization process of the whole hairpin structure, which would 
leave the path free for the ribosome. In addition, the linearization of the mRNA following 
miRNA interaction might prevent protein interaction associated with the hairpin structure. 
From another point of view, it could also be interpreted that the miRNA could hamper the 
folding of this hairpin by binding to the mRNA before the closing of the structure. 
To test the interaction between the activator miRNA and the highly structured bicistronic 
mRNA, reporter constructs were developed to decipher the mechanisms regulating the 
translation of the ICP22-US10 bicistronic transcript. 
The initial step in generating the reporter constructs required the mutagenesis of the cryptic 
PAS to maintain the bicistronic nature of all constructs. 
  
Figure 13 : Mutation of the minor PAS 
of the bicistronic transcript. A) 
Involvement of the alternative PAS with 
the bicistron transcription. When GFP is 
inserted downstream of the minor PAS, a 
GU-rich region is brought right after the 
signal which increases the termination at 
this site. Mutating the PAS standardize 
the transcription by only allowing 
bicistronic transcripts. B) Electrophoresis 
gel revealing the amplicons of ICP22-
pAmut and pAmut-US10-UTR that are 
used for the overlap PCR. The surrounded 
bands were purified to perform the 
overlap PCR. The sizes of the initial 
amplicons are 830bp for the NheI-ICP22-
pAmut fragment and 817bp for the 
pAmut-US10-UTR-HindIII fragment. 
Two concentrations of template DNA 
were tested: 0.01ng (lanes A and C) and 
0.1ng (lanes B and D). C) Electrophoresis 
gel revealing the result of the overlapping 
PCR. All the lanes represent the same 
PCR product loaded in 4 pits. The size of 
the amplicons is 1623bp. D) 
Electrophoregram resulting from the 
Sanger sequencing at Eurofins 
Genomics© industries. The figure depicts 
the nucleotides bases ranging from the 
760th position to the 790th. The mutated 
site is located between position 773 and 
779. 
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3.2) Mutation of an internal poly-A signal within the bicistronic ICP22-US10 mRNA 
Transcription termination occurs in a specific context. This context includes the PAS and a GU-
rich region 20 nucleotides downstream the PAS (Garrido-Lecca et al., 2016; Porrua and Libri, 
2015). 
Previous data obtained by 3’ rapid amplification of cDNA ends (Boumart et al., 2018) revealed 
the presence of two PAS in the sequence of ICP22, one minor and one major. The minor one 
leads to polyadenylation in 5% of the transcripts and is located upstream US10. However, this 
proportion may increase in the case of some of the constructs described in the next points, if a 
GU-rich region is brought downsteam the minor PAS. In order to standardize the reporter assays 
with the large variety of constructs, the cryptic PAS between ICP22 and US10 was removed by 
site-directed mutagenesis. The ATTAAA sequence was replaced by an ATATAT one. Two 
PCR fragments were generated to introduce the target mutation. The mutated construct was 
produced by overlapping PCR gathering mutated amplicons. After sequencing, the 
electrophoregram showed that mutagenesis of this cryptic PAS was successfully obtained. This 
initial step brings that reference material to generate reporter construct that will produce 
bicistronic mRNA in the most straightforward way. 
 Figure 14 : Design of the reporter constructs to decipher the mechanism involved in the regulation of ICP22-
US10 bicistronic transcript. A) Representation of the reporter constructs and the involved ORF. The white boxes 
represent the restriction sites, the black boxes represent the native genes, the green boxes represent the reporter 
genes, the lines represent the IgR, the yellow triangles represent the mutations, the white reversed triangles 
represent the canonical PAS, the indigo reversed triangle represent the APAS. B) Electrophoregram confirming 
the mutation of the miRE in the mutated constructs. 
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3.3) Establishment of reporter constructs to decipher the mechanisms regulating the 
translation of the ICP22-US10 bicistronic transcript 
Three series of constructs were first established to test the hypothesis. The first constructs were 
built in order to replace ICP22 with a fluorescent marker, the GFP, that will be used as a reporter 
in further experiments. The GFP ORF was coupled with the 3’end of ICP22 ORF possessing 
the miR-4-miRE (miR4 miRNA Response Element) or with the mutated miRE. The PCR 
fragments amplifying the chimeric GFP-ICP22 3’end (745bp) and the US10 (1117bp) were 
obtained. Overlapping PCR was used to generate the resulting reporter bicistronic wild-type 
construct (1827bp). The reporter bicistronic mutant construct (devoid of the miRE) was 
generated following the same strategy (data not shown). This series of constructs is named 
hereafter GFP-miRE-US10. 
The second series of constructs was produced to investigate the role of the hairpin that was 
found thanks to bioinformatics analysis. This series was established using the same strategy. 
However, the US10 fragment encompassed all the nucleotides involved in the structure, adding 
45 nucleotides to the amplicon. This construct was then mutated on the miRE following the 
same strategy. This series is named hereafter GFP-hp-miRE-US10. 
In the third series of constructs, we aimed to replace US10 by GFP. The GFP ORF was here 
coupled with the WT ICP22 ORF or with the ICP22 ORF mutated at the miR-4 binding site. In 
order to transfer the original major PAS of the bicistron into the reporter constructs, the strategy 
required to include 3 overlapping fragments, the first one amplifying either WT or mutated 
ICP22 ORF (845bp), the second one amplifying the GFP ORF (729bp) and the third one 
amplifying US10 3’UTR including the major PAS (165bp). The final construct was obtained 
by gathering these overlapping fragments (1702bp). This series is named hereafter ICP22-
miRE-GFP. 
The whole series of WT and mutated constructs generated above were produced with restriction 
sites adapted to molecular cloning downstream a CMV promoter. The integration into the same 
plasmid backbone (pcDNA 3.1 - ) was used to overexpress the bicistronic reporter constructs 
in the presence of in the absence of miR-4 to test the interaction with the activator miR. The 
sequences of all the reporter constructs were confirmed by Sanger sequencing before 
transfection. Except the mutations introduced in the miRE to investigate its function, no 
sequence modifications were observed in the whole series of constructs. 
g 
Figure 15 : Transcript quantification of the reporter constructs obtained from the ICP22-US10 bicistronic 
transcript. Bar plot representations of the RNA relative quantifications next to lipofection of DF-1 cells with the 
different constructs. The cells were transfected with 500ng of pcDNA containing the constructs and with or without 
5.000ng of pcDNA containing the miRNA. The miRNA response element miRE was mutated or not in the 
constructs. RNA was extracted 24h post-transfection. RNA abundance was normalized by GAPDH and the RNA 
abundance of the construct GFP-miREwt-US10 without miRNA cotransfection was set to 1. The data represent 
the mean of values obtained by a technical triplicate. The error bars represent the standard deviation. A) Relative 
quantification of the miREwt constructs, in the absence of miR4. B) Relative quantification of the miREwt 
constructs, in the presence of miR4. C) Relative quantification of the miREmut constructs, in the absence of miR4. 
D) Relative quantification of the miREmut constructs, in the presence of miR4. 
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3.4) Quantification of the transcript shows both direct and indirect miR4 effects on the 
amount of mRNA 
A RNA quantification assay was designed to determine the importance of the sequence 
surrounding the stop codon of the ICP22 ORF. Four questions were addressed : 1) May a RNA 
secondary structure impact the gene expression at the transcriptional level? 2) Does the miRNA 
have an impact on the RNA abundance? And does the mutation of the miRE turn off this effect? 
3) Does the hairpin change the fate of the transcript in the presence of the miRNA? 4) Does the 
position of the ORF impact the stability of the transcript? 
Our data shows a five fold increase of the transcript abundance in the presence of the hairpin in 
the transcript (figure 15.A.) and a 2 fold increase of the transcript amount following the position 
of the ORF in the transcript. This result indicates that the presence of the hairpin in two series 
of the transcript alters positively the mRNA amount in the cell. 
We next investigated the effect of miR4 expression. The quantified data showed that miR4 
alters positively the amount of mRNA in each condition as revealed by the Figure 15.B.. More 
precisely, the cells cotransfected with both GFP-miRE-US10 and miR4 displayed a 17 fold 
increase compared to the non-cotransfected construct. The cells cotransfected with both GFP-
hp-miRE-US10 and miR4 or both ICP22-miRE-GFP and miR4 were 5 fold increased compared 
to the non-cotransfected construct. These results show that miR4 increases the amount of 
transcript within the transfected cells and that the presence of the hairpin in the transcript 
sponges the boost triggered by the miRNA (17 fold increase vs 5 fold increase). 
Strikingly, the mutation of the miRE showed differential effect on the mRNA amount (Figure 
15.C. compared to Figure 15.A.). The GFP-miRE*-US10 construct and the GFP-hp-miRE*-
US10 constructs showed a 2 fold increase following the mutation while the ICP22-miRE*-GFP 
construct was decreased by a factor 2 in the presence of the same mutation. This result suggests 
that both the miRE and the US10 sequence influenced the fate of the transcript. Surprisingly, 
adding miR4 to these mutated constructs (Figure 15.D. compared to Figure 15.C.) induced a 2 
fold increase in transcript abundance for GFP-miRE-US10 and GFP-hp-miRE-US10 and a 3 
fold increase for ICP22-miRE-US10. Taken together these data indicate that miR4 increases 
the abundance of the transcript even without acting directly on the first predicted miRE. 
Following the latter result where an effect of miR4 was observed in the absence of a canonical 
miRE, it was decided to investigate additional properties of this part of the transcript. Through 
in silico analysis, additional miRNA binding sites were predicted towards to passenger strand 
produced from premiR4. 
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3.5) MDV-miR-M4-3p might bind to the bicistronic transcript encoding for both ICP22 
and US10 
To find any possible interaction between MDV-miR-M4 and the bicistronic transcript, 
IntaRNA web server was used. First, secondary interactions between miR4-5p and the transcript 
were looked for without success. Next to this, it was suggested that the small amount of miR4-
3p produced from the premiR4 could bind the transcript. Since miR4 is produced thanks to a 
CMV promoter, it is possible that the premiRNA amount could be sufficient to produce mature 
miRISC complex incorporating miR4-3p which might interfere post-transcriptionally with the 
mRNA. Indeed, several miR4-3p binding sites were found in the mRNA at the level of US10 
(Figure 16). Three sites were considered as candidates for binding miR4-3p in the bicistronic 
transcript. They are located at positions 464-486, 969-984 and 1100-1113. The possible 
interaction might explain in part why the mutation of the miRE does not turn off the effect of 
miR4 on the bicistronic transcript.  
 
 
Figure 16: Predicted miRE for MDV-miR-M4-3p. The figure shows the positions of the nucleotides on the 
native bicistronic transcript. The underlined nucleotides are involved in a Wobble interaction with the matching 
nucleotide. 
 
 Figure 17: Fluorescent microscopy of the cells transfected with the reporter constructs obtained from the 
ICP22-US10 bicistronic transcript. At 24h post-transfection, constructs were cotransfected within the cells in 
the presence or in the absence of miR4 and with or without the mutation of the miRE. The figure displays the 
raw fluorescence of the cells following these (co)transfection.  
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3.6) Protein expression is determined by several parameters : the sequence, the ORF 
position and the presence of miR4 
Fluorescent microscopy (Figure 17), western blot and flow cytometry (Figure 18) were used to 
analyze the protein expression from the different reporter constructs. In order to compare the 
data obtained in transcript quantification, protein expression was evaluated to address the same 
aspects: 1) the effect of the hairpin and of the position within the bicistronic transcript; 2) the 
influence of miR4 and 3) the impact of the mutation of the miRE. 
Cells were transfected with the whole series of constructs in the presence or in the absence of 
miR4. Identical cell densities were compared in epifluorescence. To identify the factors 
influencing GFP expression. Rough comparison of the panels displayed in Figure 17 indicated 
that the position of the ORF within the transcript deeply impacted the protein expression when 
GFP replaces ICP22 or US10. Fluorescence was only visible when GFP is positioned in the 
upstream ORF (Figure 17.A.). The presence of the hairpin increased GFP expression (Figure 
17.A.). Addition of miR4 influenced positively the GFP expression with the constructs where 
GFP replaced ICP22. This effect was only visible in the presence of the hairpin (Figure 17.B.). 
Mutating miRE sequence did not reveal any effect in the absence of miR4 expression when 
Figure 17.C. was compared to Figure 17.A.. However, the mutation of the site revealed a 
striking increased fluorescence density in the construct where GFP replaced ICP22 devoid of 
the hairpin (Figure 17.D.). 
Since epifluorescence observation is not a quantitative method, it was decided to assess the 
protein expression from the reporter constructs by using flow cytometry analysis and western 
blot. 
According to protein expression of the cells transfected in the absence of miR4 with the miRE 
WT constructs (Figure 18.A.), the presence of the hairpin induced a 10 fold increase in the 
protein expression for the upstream ORF. However, when GFP replaced the downstream ORF, 
in the ICP22-miRE-GFP construct, fluorescence was slightly detected (20 times less than the 
GFP-miRE-US10 construct). These data show that both the position in the bicistronic transcript 
and the presence of an hairpin in the secondary structure were determinant for the GFP 
translation. 
When miR4 was cotransfected with the miRE wt constructs (Figure 18.B.), the protein 
expression was increased for the tested conditions. More precisely, cells transfected with GFP-
miRE-US10, GFP-hp-miRE-US10 and ICP22-miRE-GFP respectively increased the GFP 
expression by a factor 5, 4 and 6. What is worthy to note is that GFP is still barely expressed in 
the latter situation. This result demonstrate that the expression of miR4 has a positive effect on 
the protein expression, independently of both the hairpin and the position of the ORF in the 
bicistronic transcript. 
The mutation of the miRE in the absence of miR4 increased the GFP expression in the whole 
series of constructs (Figure 18.C.). The two constructs including the hairpin (GFP-hp-miRE*-
US10 and ICP22-miRE*-GFP) showed a 1,5 fold increase, meanwhile the construct without 
the hairpin (GFP-miRE*-US10) showed a 9 fold increase. Adding miR4 to these constructs 
(Figure 18.D.) increased the GFP expression by a factor 2 for the constructs possessing the 
hairpin (GFP-hp-miRE*-US10 and ICP22-miRE*-GFP) and by a factor 4 for the sequence 
devoid of the hairpin (GFP-miRE*-US10).  
Altogether, these patterns of protein expression first show that the hairpin sponge a deleterious 
effect for the translation at the miRE, which is compensated by the mutation of this site. The  
 Figure 18: Single cell analysis of the protein expression associated with the reporter constructs obtained 
from the ICP22-US10 bicistronic transcript. Bar plot representations of the fluorescence relative quantifications 
following transfection of DF-1 cells with the different constructs. The cells were transfected with the constructs in 
the presence or in the absence of the miRNA. The miRNA response element (miRE) was mutated or not in the 
constructs. Cells were analysed by flow cytometry 24h post-transfection. Fluorescence of the construct GFP-
miREwt-US10 without miRNA cotransfection was set to 1. A) Relative fluorescence of the cells next to 
transfection with miREwt constructs, in the absence of miR4. B) Relative fluorescence of the cells next to 
transfection with miREwt constructs, in the presence of miR4. C) Relative fluorescence of the cells next to 
transfection with miREmut constructs, in the absence of miR4. D) Relative fluorescence of the cells next to 
transfection with miREmut constructs, in the presence of miR4. 
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results also indicate that miR4 exert either an indirect enhancement of the mRNA translation or 
a direct enhancement at another unknown miRE. 
In order to confirm the unexpected result of GFP expression induced by miR4 when the miRE 
was mutated, western blot analysis was carried out (Figure 19). This preliminary assay was also 
designed to monitor the slight expression of the GFP when it is positioned in the downstream 
ORF. The Figure 15 revealed similar expression pattern as those observed by flow cytometry. 
Taken together, these results show again both direct and indirect effects of the miRNA on the 
mRNA translation. The presence of a hairpin dramatically impacts mRNA translation. 
Unexpectedly, the mutation of the miRE, in the presence of mIR4 (figure 18.B. compared to 
18.D.), increased the expression of the GFP in the transcripts devoid of the hairpin (GFP-miRE-
US10) meanwhile it decreased the expression in the sequences containing the hairpin (GFP-hp-
miRE-US10 and ICP22-miRE-GFP). This last observation indicates that the binding between 
miR4 and the hairpin impact directly on the mRNA translation. 
 
Figure 19: Western blot analysis of the protein expression associated with the reporter constructs obtained 
from the ICP22-US10 bicistronic transcript. A) Analysis of the protein abundance produced after transfection 
of the GFP-miRE-US10 and ICP22-miRE-GFP series of constructs. 25µg of protein were loaded on each lane. B) 
Analysis of the protein abundance produced after transfection of the GFP-hp-miRE-US10 series of constructs. 
25µg of protein were loaded on each lane. Negative controls are a non-transfected cell line and a cell line 
transfected with a pcDNA 3.1 (-) encoding for miR4. 
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3.7) mRNA half-life show a protective effect of miR4 on the bicistronic independent of 
the binding of miR4 to the miRE 
Since the mRNA amount was altered by the presence (or the absence) of miR4 in the cell. It 
was decided to investigate the effect of miR4 on the mRNA half-life of the bicistronic transcript. 
Investigating this aspect might show a role of a mRNA decay pathway on this specific mRNA. 
This decay would be inhibited in the presence of miR4 in the cell. It was decided to test this 
hypothesis on bicistronic transcripts that encompass the two sequences encoding the native viral 
proteins (ICP22 and US10). These transcripts were obtained by generating a new series of 
constructs with the WT or the mutated miRE. A similar cloning strategy was used as described 
above (see 3.2 and 3.3). The resulting constructs gathering ICP22 and US10 were transfected 
in the presence or in the absence of miR4. The transcription was inhibited 24h post-transfection 
and RNA extracted at 4h; 6h; 12h and 25h post-treatment. 
The preliminary data show that adding miR4 to the WT and the mutated miRE constructs 
increased the half-lifes of the mRNA of a factor 1,6. It means that miR4 effectively inhibits a 
decay pathway involved in the fate of the mRNA but this inhibition is not only dependent on 
the binding of the miRNA with the predicted miRE. 
However, these results must be reproduced and precised by carrying out multiple replicates, 
since the data seem not precise and since some samples failed to be quantified precisely. The 
clearly failed samples were removed from the data, having an influence on the results. 
 
Figure 20: miR4-mediated alteration of the mRNA half-life. A) Newly synthetized constructs that were 
transcfected in the cells, in order to measure the half-life of the bicistronic transcript B) Relative RNA abundance 
over time after inhibition of the transcription by dactinomycin treatment. Both the constructs ICP22-US10 with or 
without a mutated miRE were transfected in the presence or in the absence of miR4. The dactinomycin treatment 
was carried out 24h post-transfection and the RNA was extracted at 1;4;6;12;25h post-treatment. The RNA amount 
was standardized using GAPDH (considered and confirmed as a stable transcript) and the ∆∆Ct was calculated 
using the non-treated control at the first time-point. The R2 of the linear regression are of 0,9351 for miRE WT  
without miR4; 0,6935 for miRE WT + miR4 cotransfected ; 0,9574 for miREmut without miR4 ; 0,6752 for 
miREmut + miR4 cotransfected. 
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4) Discussion 
Understanding how gene expression is regulated is crucial since dysregulation of the gene 
expression is a hallmark of cancer. Indeed, every cancerous process displays a gene expression 
pattern with increased proto-oncogenes and decreased the tumor suppressor genes are 
decreased. Investigating such phenomenon in a model of virus-induced lymphomagenesis 
offers several advantages. In this context, we worked on the regulating processes of a specific 
bicistronic transcript encoding US10 and ICP22 proteins, the latter being known to play a role 
in tumorigenesis. ICP22 gene expression was shown to be positively impacted by a miRNA. 
By using GFP reporters, it was aimed to decipher and to understand the whole pathway involved 
in the miRNA dependent increase of protein expression from a bicistronic transcript. Our data 
bring new findings that characterize the regulation of the expression of the viral genes encoded 
by the bicistronic ICP22-US10 transcript. The first insights were brought by Boumart and 
collaborators (Boumart et al., 2018) when they proved the involvement of miR4 in the 
upregulation of the ICP22 translation following the binding with the stop codon of the ICP22 
ORF. In their constructs, they only explored the regulation in a monocistronic model. This 
model revealed an essential role of miR4 in turning on ICP22 expression but did not allow to 
describe functions for each part of the bicistronic transcript. An original series of bicistronic 
reporters were set up to explore the mechanisms of expression through a diversified approach. 
By comparing both the transcript and the protein amounts in the different tested conditions, this 
approach permitted investigating the roles of the different portions of the transcript. 
We revealed through transcript quantification the importance of the stop codon-associated 
hairpin, of the stop codon-associated miRE and of the concomitant expression of miR4. 
Regarding the hairpin, it was shown to increase the transcript amount. The presence of miR4 
was confirmed to increase the mRNA amount within the cells while the mutation of the miRE 
had variable effect according to specific sequence arrangement. The position of the GFP ORF 
was shown to have an impact on the transcript abundance. This effect was associated with the 
presence or the absence of the US10 ORF. This observation is supported by the presence of two 
potential miRE for miR4-3p in the sequence of US10. It is likely that the binding of miR4-5p 
at the first miRE and the binding of miR4-3p to a secondary miRE triggers the formation of a 
complex able to inhibit a decay pathway. 
Reporter constructs were designed to include or to exclude a highly structured hairpin within 
the bicistronic RNA. Data from RNA and protein quantifications pointed out the importance of 
the hairpin both in the abundance and the fate of the transcript. It is suggested that, more than 
just protecting directly the mRNA, miR4 targets directly mRNA decay factors, having thereby 
an indirect positive effect on the bicistronic transcript amount. This observation is confirmed 
by quantification of the mRNA over time after inhibiting the transcription with dactinomycin 
since miR4 induced an increase of the half-life of the mRNA even in the absence of the 
canonical miRE. 
 Figure 21 : Suggested models of the miR4-induced upregulation of a bicistronic transcript. DF = Decay 
Factors A) Canonical termination of the translation, as explained in Figure 3. B) Model of an indirect miR4-
induced effect on the transcript. In this case, miR4 would inhibit some decay factors that impair the transcript 
amount. C) Model of a direct miR4-induced effect on the transcript. In this case, the binding of the miRISC 
complex would inhibit the recruitment of decay factors (such as Upf-1) at a site located far from the poly-A tail 
and PABP, the canonical inhibitor of Upf-1.   
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4.1) Suggested models to explain miRNA-dependent increase of the gene expression 
Based on our data and literature, a series of non-exclusive models are suggested to explain the 
miR4 dependent enhancement of the gene expression. These models are developed and 
illustrated by previously published examples. The first model (Figure 21.B.) relies on the 
inhibition of decay protein by miR4. In a GaHV-2 infection, Tahiri-Alaoui and colleagues 
(Tahiri-Alaoui et al., 2014) already demonstrated that kind of effect following indirect miRNA-
mediated increase of the expression. In this example, the pp14 polyprotein was increased by 
the miRNAs produced from the LAT miRNA cluster. They showed how the miRNAs increased 
the recruitment of PABP to a transcript to increase the cap-independent translation. More 
precisely, the LAT-derived miRNAs were targeting the paip2-encoding transcript. Paip2 
interferes negatively with PABP. By inhibiting this inhibitor, in a miRNA-mediated way, the 
total amount of available PABP increase, upregulating therefore the PABP-dependent 
translation. Based on this example, the model that is suggested is likely to happen since we 
proved an indirect effect of miR4 on the transcript stability. However, this indirect mechanism 
is not exclusive since we also proved another direct effect. Following this idea, several models 
were developed to provide with a comprehensive lecture of all the mechanisms that are likely 
to be involved in the miR4-dependent enhancement of the gene expression. Considering that 
each model might be associated with one or several alternative model, this offers a huge 
combinatory series of events that need to be investigated and confirmed one by one. 
Stabilization of a transcript by a miRNA is already a known mechanism. An example is the 
TTP mechanism (Ma et al., 2010), in which a miRNA protect a mRNA by binding to an ARE 
previously targeted by the TTP. This protein is unfortunately absent in birds (Lai et al., 2013), 
including the chicken, and therefore cannot be the key of the miR4-mediated upregulation of 
the transcript. Nevertheless, this protein is an important anti-inflammatory factor, that could 
have a homolog in the chicken organism. Thus, this mechanism should not be discarded in the 
case of the miR4-mediated upregulation of the bicistronic transcript. To support this hypothesis, 
the bioinformatics analysis showed the presence of an ARE overlapping the stop codon of the 
ICP22 ORF. The second and third models are based on this ARE-identified pathway. 
Concerning the second model (Figure 21.C.), it assumes that the ARE is an instable part of the 
bicistronic transcript targeted by a protein homolog or not to TTP and that the binding of this 
protein is inhibited by the miRNA. During the viral infection, miR4 would synergize with 
ICP27 to exert the positive effect. Indeed, ICP27 has been shown to induce factors that stabilize 
ARE-containing transcript (Corcoran et al., 2006) and was also shown to increase the 
expression of ICP22 (Boumart et al., 2018).  
The HCV illustration of miRNA-induced stabilization of an RNA molecule was described in 
the introduction of this master thesis (see 1.2). It was demonstrated that two miRNA strands, 
bound at two sites in the vicinity of a hairpin, stabilized the structure of the targeted RNA, 
insuring thereby its whole integrity. In the third illustrated model (Figure 22), we suggest a role 
of both miR4-5p and -3p on the stability of the transcript. This model is suggested to happen 
through three interactions : between miR4-5p and ICP22 ORF ; between miR4-3p and US10 
ORF and between both miR4-5p and -3p. These three interactions might impact the secondary 
structure of the bicistronic transcript, leading to a supercoiled mRNA which would not be 
accessible for decay factors at the ARE level. It is important to note that this model does not 
exclude that another important structure might impact the conformational shift. 
The second and third model share a common feature since they are likely to happen within the 
nucleus, at a early post-transcriptional level, impairing further binding of any decay factors on 
the mRNA. 
  
 Figure 22 : Suggested models of the miR4-induced upregulation of a bicistronic transcript (continuation). 
DF = Decay Factors. ORFs are represented by black lines, intergenic sequence are represented in grey and proteins 
are represented in green. A) Example of a bicistronic transcript binding by a miRNA at two different sites and 
displaying a hairpin at the end of the first ORF. B) Canonical conformation of the same bicistronic transcript in 
the absence of miRNA-miRNA interaction. DFs are supposed to target the sequence nearby the miRNA target. C) 
Conformational change in the presence of an interaction between the two miRNA, protecting hampering the 
binding of the DFs to their target sequence. 
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In 2017, Wakiyama and collaborators (Wakiyama et al., 2018) described an enhancement of 
the protein expression illustrated by using of a luciferase reporter system. This increase was 
mediated by an interaction between PABP and TNRC6, which take part in the RISC complex. 
The particularity of this example is that the expression boost happened only in the absence of a 
poly-A tail in the luciferase transcript and in an IRES-dependent translation. In the case of the 
ICP22-US10 bicistronic transcript, it was proven by a poly-T dependent 3’RACE that the 
transcript is polyadenylated by the US10 3’UTR. However, since PABP is able to interact with 
Ago, a model (Figure 23) is suggested to explain the miR4-induced enhancement of the gene 
expression. In this model, the binding of the miRNA with the first stop codon would affect the 
secondary structure of the bicistronic transcript by establishing an interaction between PABP 
and the stop codon. This interaction could either inhibit decay factors, such as Upf-1 which was 
proven to be inhibited by PABP, or increase the translation like in the described example. 
The upregulation might also result from a transcriptional effect. saRNAs are a class of miRNAs 
that were shown to be functional within the nucleus after binding generally to a promoter to 
increase the transcription following the recruitment of transcription factors. The first known 
example of saRNA was described in 2008 (Place et al., 2008). By targeting the e-cadherin gene 
with miRNA matching with 3’UTR, in order to knock-down the protein that they were studying, 
Place and collaborators have experienced one of those serendipity effects in research. Indeed, 
the candidate miRNA increased rather than decreased the e-cadherin expression. By 
investigating the process underlying the unexpected activation, the authors showed a strong 
match between the sequence of both the miRNA and the e-cadherin promoter. In the case of the 
ICP22-US10 bicistronic transcript, the miRE is located at the end of the ICP22 ORF. To our 
knowledge, a saRNA was never shown to exert its function at a distal site from the promoter. 
Moreover, the presence of a functional RNA hairpin involved in the upregulation does not 
provide with compelling evidence that the regulation occurs at the transcriptional level. 
Nevertheless, this hypothesis may be a fragment of the answer since the hairpin is not the only 
part involved in the regulation. Furthermore, it is not known if miR4 could target the CMV 
promoter that is used in the plasmid backbone that was used to clone the whole diversity of 
constructs. Preliminary data found one site susceptible of being targeted by miR4 in the CMV 
promoter but the predicted interaction is rather weak when compared with the given example. 
 Figure 23 : Suggested models of the miR4-induced upregulation of a bicistronic transcript (end). A) 
Inhibition of the gene expression at a transcript level, induced at a premature termination codon by decay factors, 
such as Upf-1. B) In the presence of a miRNA at the first stop codon, the miRISC complex interacts with PABP 
through the TNRC6 protein. C) The interaction between RISC and PABP induce a conformational change that 
bring the premature stop codon in the neighborhood of PABP, which inhibits the decay factors. 
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4.2) miRNA dependent increase of the gene expression involves interaction with 
secondary RNA structure 
In the initial description of the miR4-dependent ICP22 expression, another mechanism was 
suggested. The idea was that the ICP22-US10 bicistronic transcript was degraded through NMD 
in the absence of miR4. In this case, it is assumed that the stop codon of the ICP22 ORF is 
considered as a PTC by the translation machinery, recruiting thereby Upf-1. This idea is 
supported by several sequence features. First, in the case of a bicistronic transcript, the 3’UTR 
of the first ORF is pretty long, since it encompasses a second ORF. A recent study from May 
and collaborators (May et al., 2018) described a mechanism used by a RNA virus to resist 
against NMD. Because of their polycistronic constitution, most of the RNA viruses display long 
3’UTR associated to the ORFs localized near the 5’ end of the unique viral transcript and are 
assumed to be targeted by NMD when infecting an eukaryotic cell. Most of their strategies to 
escape NMD are still to be described. In the case of Turnip Crinkle Virus (TCV), the 3’UTR 
has an unstructured sequence right after the stop codon. When an hairpin replaced this 
unstructured region, NMD was activated, impairing thereby the viral replication. This fact 
might explain why a bicistronic transcript like gK-ICP27 seems not to be targeted by NMD 
(Strassheim et al., 2016). Indeed, bioinformatics analysis revealed no specific structures in the 
regions surrounding the stop codon of the gK ORF. In the case of the ICP22-US10 bicistronic 
transcript, the bioinformatics analysis revealed a highly structured hairpin. It was first assumed 
that this hairpin was unfolded by miR4 and the RISC, leading to a resistance against NMD but 
our data showed a miR4-mediated increase of the fluorescence even in the absence of the miRE. 
It is possible that the hairpin structure might be hampered by the mutation, but bioinformatics 
analysis (data not shown) did not reveal any change. 
A sensitive question refers to the fact that miR4 expression, in the case of a binding to the 
bicistronic transcript, does not lead to Ago-RISC-mediated inhibition meanwhile the vast 
majority of the literature describe the inhibitory effects mediated by the miRNAs. It was 
recently described a role of the FAM120A protein which was associated to polynucleotide 
regions. This protein was identified in up to one third of all known miRNA transcripts.The 
presence of this protein (FAM120A) was demonstrated to decrease the effect of the miRNAs 
on their target. In the case of ICP22-US10, a poly-C site was found in the intergenic region of 
the transcript. FAM120A might bind with this poly-C stretch decreasing thereby the deleterious 
effect of RISC. Moreover, the involvement of an hairpin in the regulation of the bicistronic 
transcript suggest that this structure might act as a recruitment platform to catch proteins that 
would impair RISC activities. Another possibility is that this structure would be able to maintain 
decay factors at too long distance to exert their effect on the transcript. A described example of 
secondary structures that sponge decay proteins comes from RNA viruses belonging to the 
Flaviviridae family (Michalski et al., 2019). More precisely, Zika virus and dengue virus both 
produce a subgenomic flavivirus RNA (sfRNA) that is strongly structured. It was shown that 
these specific RNA recruit a lot of proteins involved in decay mechanisms that are usually 
deleterious for the RNA genome of the virus. It is suggested that the hairpin observed in the 
bicistronic transcript embedding ICP22 and US10 might act the same way than the sfRNA by 
recruiting decay factors, inhibiting thereby their activities. 
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4.3) Optimization process to increase significance of assays that were carried out during 
the master thesis 
The very first step of this project was to analyze widely the features of the mRNA, using a 
bioinformatics approach. At first glance, a highly structured hairpin was predicted in silico, this 
candidate structure becoming an important part of the global project. Nonetheless, RNA folding 
was not demonstrated through experimental approach neither in vitro nor in vivo. It cannot be 
excluded that the observed effects in the presence of the hairpin sequence depends more on the 
primary structure than the secondary one. There should be a new series of constructs to mutate 
the sequence silently, without impacting the hairpin, assessing thereby the role played either by 
the nucleotide sequence or by the RNA folding in the regulation of the gene expression. 
As first wet lab experiments, an alternative PAS was mutated in the intergenic region of the 
bicistronic transcript. It was aimed to avoid background noise associated with monocistronic 
transcripts (5% of the total mRNA produced from the native ICP22-US10 transcriptional unit). 
However, even if the mutation was a success, it was never proven that it has really an effect on 
the polyadenylation process at this position. Further experiments should be carried out to 
confirm the absence of monocistronic transcript embedding only GFP. Nevertheless, qPCR 
results at least confirm the presence of bicistronic transcripts since the primers were designed 
on the GFP sequence. Since amplicons were detected when it was positioned in the downstream 
ORF, it indicates that the reporters mutated at the alternative PAS produce full length mRNAs. 
Another way to increase the reliability of our results, based on an artificial model, is to change 
the selected reporter system with another one, such as luciferase in future constructs. At first, it 
was decided to use GFP. This reporter allows performing single cell analysis (Figure 18) and 
direct observation (Figure 17) by fluorescent microscopy. It was also convenient since the 
preliminary results (Boumart et al., 2018) indicated a miR4-induced “on/off” effect. In addition 
the sequence length corresponding to GFP ORF is more representative of the two native genes 
encoded by the bicistronic transcript. However, quantification using GFP remains less precise 
than luciferase. Since it is now obvious that reporter luciferase constructs fit better for studying 
the miR4-mediated regulation, a new series of reporters would be established by using the 
renilla luciferase as reporter gene. It would allow having a more sensitive tool to measure the 
effect of both the hairpin and miR4 on the translation. 
In the results and discussion, it was concluded that the position of the ORF in the sequence alter 
its expression since GFP was less expressed when placed at the second position of the transcript. 
However, when the transcript encompass both ICP22 and GFP, we predict a strong expression 
of ICP22. This protein was shown to impair the transcription with all the tested promoters 
(Boumart et al., 2018). The precise mechanism still has to be described but is likely to involve 
the inhibition of the RNAPII. Therefore, the impairment of ICP22 on the transcription, 
including on the CMV promoter, would inhibit the expression of the whole transcript. Since 
GFP-hp-miRE-US10 and ICP22-miRE-GFP constructs are imbalanced in terms of ICP22 
expression, this introduces an interpretation bias. Indeed, the lower amount of ICP22-miRE-
GFP transcript compared to the GFP-hp-miRE-US10 transcript might be attributed to the 
presence of ICP22 only in the first situation. To investigate the roles of the hairpin and the 
miR4-miRE interaction without ICP22 interference, construct design would substitute both 
ORF with discriminative reporters. 
Eventually, since the constructs were available 6 weeks before completing this manuscript, 
experiments were realized as single assays. Even if the reproducibility has not been tested yet, 
we observed dramatic effects induced by the presence of the hairpin and of miR4 expression in 
the different readouts (RT-qPCR, western blot, flow cytometry, epifluorescence, mRNA half- 
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life assessment). Data should be analyzed with appropriate statistical tests including biological 
replicates. At the present time, results are representative of technical replicates (qPCR). 
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4.4) Conclusion and perspectives 
On the opposite of the linear view of the steps involved in the gene expression, reporter 
constructs designed from a viral bicistronic mRNA pointed out the importance of secondary 
structures as well as the positive influence of miRNA in the fate of a mRNA. Viruses are 
therefore adequate organisms to study molecular mechanisms that tightly regulate the gene 
expression. Three major findings emanated from this project: 1) a RNA hairpin increases the 
gene expression of an important viral protein; 2) the mRNA of the same gene is targeted by a 
miRNA, increasing its abundance and translation and 3) both direct and indirect effect of this 
miRNA were demonstrated. Altogether these data shed light at the different levels where gene 
expression might be regulated by RNA secondary structure or by miRNAs. To explore each of 
these levels, several non-exclusive models were suggested. 
To decipher the whole pathway that was described in this master thesis, the first step would be 
the inhibition of some mentioned decay pathways. For example, the use of a competitive 
inhibitor of Upf-1 in the presence of the construct would increase the expression of the GFP in 
the absence of miR4 if this pathway is behind the miR4-mediated regulation. 
The next step would be the use of the RaPID (RNA–Protein Interaction Detection) method 
(Ramanathan et al., 2018) to understand the precise role of the hairpin in the involved pathway. 
This mechanism involves the generation of a new construct in which the hairpin would be 
surrounded by two structures linked to the BirA protein. This protein biotinylates all the 
surrounding protein which are therefore allowed to be purified using streptavidin-coupled 
beads. The analyze by MS/MS spectrometry would next allow identifying candidates that might 
interfere with the involved pathway. 
To finalize these results, establishing recombinant viruses with the same features than the 
presented constructs would bring a confirmation of the existence of the pathway in the natural 
infection context. 
This fact could be taken in account in the engineering of new vaccine strains. More precisely, 
it was never tried to overexpress a deleterious protein, to attenuate the virulence of a virus. We 
also suggest a new genetically engineered type of vaccine that would encompass a protein that 
inhibit latency, such as ICP4. In this case, the hairpin and miR4-miRE would be added to the 
ICP4 sequence to increase its expression during latency. This could inhibit the virus escape 
from the immune system and allow the chicken to develop antibodies against the disease before 
it turns out to induce lymphoma.  
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